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Abstract  
The Sf9 cell line, as a component of the Baculovirus Expression Vector System (BEVS), 
is a popular platform for industrial-scale production of protein products. However, the natural 
course of the BEVS results in host-cell lysis before many down-stream protein modifications 
can be made, making it suboptimal for production of complex products such as membrane or 
glycosylated proteins. Stably transforming a Sf9 cell line for constitutive expression of a gene 
product can effectively circumvent this issue, however the process of developing these cell 
lines remains inefficient and time-consuming. 
Synthetic biology is a field of research that approaches biological problems through the lens 
of engineering design. With this in mind, a design for a Sf9 line was developed that leverages 
fC31 Integrase technology to facilitate Recombinase Mediated Cassette Exchange (RMCE) in 
vivo in the Sf9 host cell. RMCE is a type of site-specific DNA recombination that results in 
the exchange of a DNA cassette from, in this case, a donor plasmid to a genomic locus within 
the host cell.  
A pair of fluorescent reporter proteins, mAzamiGreen and mKOk, were tested to determine 
their suitability for use in confirming successful cassette exchange in Sf9. These were found 
to be easily differentiable in both mixed culture and co-transfection scenarios.  
Additionally, some insight was gleaned with respect to media formulation when performing 
a limiting dilution protocol on Sf9 cells. Culturing cells in a 50/50 Fresh/Conditioned media 
formulation showed increased cell viability when compared with 100% conditioned media. 
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The addition of FBS drastically improved cell viability after 1 week. However, the difference 
between 2% and 10% FBS supplementation was not significant.  
The genetic components of the design were assembled via Splice Overlap Extension PCR 
and Gibson Assembly protocols. However, complications during the construction of the 
genetic architecture meant that the design was not seen to completion. Nevertheless, the lessons 
learned throughout this work will aid in future attempts to develop the proposed system. 
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Chapter  1  
Introduction  
1.1  Production  of  Recombinant  Proteins  Through  Animal  Cell  Culture  
The field of biotechnology might easily be thought of as a modern one, but its roots extend 
back all the way to 1907. It was in that year that Ross Harrison first demonstrated of cell growth 
in vitro, by maintaining frog cells in a hanging drop for as many as four weeks (Harrison, 
Greenman, Mall, & Jackson, 1907).  It would take several decades for this discovery’s 
ramifications to cement, but the field would then proceed rapidly. The 1949 discovery that 
poliovirus could be cultured in vitro quickly led to the first industrial use of animal cell culture 
– the production of the Salk poliomyelitis vaccine in 1954 (Enders, Weller, & Robbins, 1949; 
Kretzmer, 2002).  Soon, there began a wave of vaccines produced by way of animal cell 
culture, including Foot-and-Mouth, Measles, Rabies, Mumps, and Rubella (Kretzmer, 2002).  
But these pharmaceuticals, while landmarks in their own right, were all “native” biologics. 
What about more complex or recombinant products? 
 Beginning in the 1980’s, recombinant protein production in mammalian cell culture 
became a reality. Human Tissue Plasminogen Activator was produced by inserting the tPA 
gene into Chinese Hamster Ovary (CHO) cells, and it became the first licenced recombinant 
protein produced in animal cell culture (Lubinieki 1989).  While CHO cells are still the most 
frequently used host in the mammalian cell culture space, others such as human embryonic 
kidney (HEK-293), human-retina-derived (PER-C6), or baby hamster kidney (BHK) cells are 
common as well (Butler, 2005).  With respect to producing pharmaceuticals for human 
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consumption, these mammalian platforms offer advantages such as precise glycosylation and 
post-translational modifications of the product.  
However, many recombinant protein products can be accurately reproduced outside of a 
mammalian cell. In such cases, insect cell culture is a more economically attractive option. 
Additionally, insect cell culture provides access to high-output recombinant protein production 
through a virally mediated system called the BEVS. 
 
1.2  The  Baculovirus  Expression  Vector  System  
BEVS is a popular platform for recombinant protein expression. The BEVS consists of two 
main components – the Autographa californica Multicapsid Polyhedrovirus (AcMNPV) and a 
eukaryotic (often lepidopteran-derived) host cell.  
 AcMNPV is a large enveloped dsDNA virus, belonging to the Baculoviridae family 
(Jehle et al., 2006).  The virus’s native hosts are invertebrates from orders such as Diptera, 
Hymenoptera, and Lepidoptera (Jehle et al., 2006).  The Baculovirus lifecycle is split into 3 
distinct phases: early phase (0-6 hpi), late phase (6-24 hpi), and very-late phase (24-72 hpi). 
During the very-late phase, AcMNPV is known to produce distinct occlusion bodies. Two 
genes in particular, polh and p10, contribute heavily to the development of this phenotype by 
contributing the lion’s share of the matrix in the occlusion bodies (van Oers, Malarme, Jore, & 
Vlak, 1992).  The polh and p10 promoters are considered to be some of the strongest promoters 
currently known. The BEVS derives its utility by leveraging the power of these two promoters, 
and the fact that the genes they drive are not obligatory for replication in cell culture (Kost, 
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Condreay, & Jarvis, 2005; van Oers, Pijlman, & Vlak, 2015).  By replacing the coding 
sequences (CDS) of either the polh and/or p10 genes with a gene of interest (GOI), 
extraordinary amounts of GOI-coded protein can be obtained upon infection of a host cell with 
the recombinant baculovirus (Smith, Summers, & Fraser, 1983). 
 Since the inception of the BEVS, significant changes have been made to the AcMNPV 
genome in an effort to improve the system’s ease-of-use, viral stability, as well as the quality 
and quantity of the protein products (Kitts, Ayres, & Possee, 1990; Pijlman, van Schinjndel, & 
Vlak, 2003).  These improvements have led to increased use of the BEVS in research 
applications, as well as industrially to produce proteins, Virus-Like Particles (VLPs), and viral 
vectors for both human and veterinary applications. 
 While AcMNPV has a variety of potential hosts, there are two in particular that are 
commonly used in industrial applications. Ovarian tissue samples of Spodoptera frugiperda 
and Trichoplusia ni gave rise to the cell lines Sf9 and Hi-5, respectively (Hink, 1970; Vaughn, 
Goodwin, Tompkins, & Mccawley, 1977).  The Sf9 cell line is a clonal isolate derived from 
the original S. frugiperda line Sf21, and is adapted to grow in serum-free media. The Sf9 line 
can be grown both adherently or in suspension, and is suitable for both transfection and 
recombinant protein expression. However, despite the significant advances made to the BEVS 
through engineering the AcMNPV genome, less attention has been paid to how the Sf9 genome 
might be optimized. 
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1.3  Genome  Engineering  via  Site  Specific  Recombination  
DNA recombination refers to any reorganization of two or more strands of DNA into a new 
configuration. This can occur naturally during the routine life-cycle of an organism, such as 
instances of homologous recombination, or can be performed in a laboratory setting where the 
process is termed “cloning.”  
Conservative site-specific recombination (CSSR) is a particular method wherein regions 
of DNA can be excised, inverted, integrated, or otherwise translocated based on sequence-
specific criteria. This form of recombination is typified by three important factors: i) the 
recombination event is catalyzed by a specialized enzyme, a site-specific recombinase (SSR); 
ii) recombination takes place only at unique sequence-specific loci; and iii) recombination does 
not require DNA synthesis in order to proceed (Grindley, Whiteson, & Rice, 2006). 
 There are two main classes of SSRs, the tyrosine recombinases (TR) and the serine 
recombinases (SR), so identified by their catalytic amino acid residue (Brown, Lee, Xu, & 
Smith, 2011).  Each of these can be further partitioned into two subgroupings; TRs are divided 
broadly by their directionality, whereas SRs are done so by size (Wang, Kitney, Joly, & Buck, 
2011).  While these classes of SSRs are evolutionarily and mechanistically distinct, they follow 
analogous principles of operation. The SSR(s) recognizes and binds to two sequence-specific 
regions of DNA, forming the synaptic complex. While in the synaptic complex, the SSR 
cleaves, exchanges, and recombines the segments of DNA. Once the recombination is 
complete, the synaptic complex dissolves (Grindley et al., 2006). 
 Genome editing is more challenging than in vitro cloning. In most cases, genome 
editing harnesses the natural DNA repair mechanisms of a cell to make site specific changes 
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via homologous recombination (HR) (Camerini-Otero & Hsieh, 1995).  This technique, while 
serviceable, is extremely inefficient when compared with SSR techniques (Groth, Olivares, 
Thyagarajan, & Calos, 2000; Mumm, Landy, & Gelles, 2006). 
 In the past thirty years, SSRs have become a useful tool in engineering plant species. 
They can be used in conjunction with HR (such as to remove selectable markers after HR), or 
to directly introduce transgenes into plants such as thale cress, tobacco, and rice (Choi, Begum, 
Koshinsky, Ow, & Wing, 2000; Dale & Ow, 1991; Louwerse et al., 2007; Srivastava & Ow, 
2001).  
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1.4  Hypothesis  
Incorporating CSSR capabilities from Phage C31 into the Sf9 genome will allow for rapid and 
stable gene integration at an individual genomic locus via fC31-Integrase mediated cassette 
exchange. 
 
1.5  Research  Objectives  
1.5.1  Design    
The design phase sought to identify key features that a successful SSR-competent Sf9 cell 
line should exhibit. Potential genetic components were evaluated based on previously reported 
studies and/or current experimentation. A gene architecture was then designed to accommodate 
as many system features as possible, such as orthogonality and irreversibility.   
1.5.2  Construction  
A series of in vitro DNA cloning techniques, such as Splicing Overlap Extension 
Polymerase Chain Reaction (SOE-PCR) and Gibson Assembly, were used in an effort to 
construct the gene architecture. 
1.5.3  Implementation  
The completed gene architecture would then be integrated into the Sf9 genome via 
piggyBac transposon technology (a transposon derived from T. ni). A limiting dilution protocol 
will be used to isolate monoclonal cell lines from the resulting culture of SSR-competent cells.   
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Chapter  2  
Literature  Review  
2.1  Site  Specific  Recombination  
There are an estimated 2.9x1029 bacteria currently living on planet Earth (Kallmeyer, Pockalny, 
Adhikari, Smith, & D’Hondt, 2012).  While this is an astounding number, an even larger 
number is required to describe the Earth’s population of viruses. Viruses are the most numerous 
genetic beings in the world, with over 1030 in the oceans alone (Suttle, 2007).  Given the size 
of the world’s bacterial population, it is unsurprising that the majority of the planet’s viruses 
are bacteriophages; they outnumber bacteria 10 to 1 (Hambly & Suttle, 2005).  Two types of 
bacteriophage lifecycles exist: lytic and lysogenic. The lytic cycle, involves a relatively 
straightforward itinerary of infection, replication, and lysis of the host cell. Under some 
circumstances, bacteriophage can engage in a lysogenic cycle. During this process, the viral 
genome is integrated directly into the host cell’s DNA. The virus, now called a prophage, can 
lay dormant until triggered to activate by environmental conditions, at which time the prophage 
DNA is excised from the host and the lytic cycle begins again (Ptashne, 2004). 
 This integration and excision of the phage genome is mediated by CSSR. The 
phenomenon of CSSR was initially described by Allan Campbell in 1962. He observed that 
the integration of Escherichia coli phage λ required a cross-over event between a specific DNA 
attachment site in the bacteria (attachment Bacteria, or attB), and a corresponding site in the 
phage (attachment Phage, or attP) (Campbell, 1963).  The enzyme responsible for orchestrating 
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this cross-over, λ Integrase (λInt), was isolated in 1974, and would become the prototypical 
specimen for CSSR (Nash, 1974). 
 CSSR can also be used by mobile DNA elements throughout the bacterial and archaeal 
kingdoms, on plasmids and transposons (Kostrewa et al., 1991; Phoebe A. Rice, Yang, 
Mizuuchi, & Nash, 1996).  But despite their near ubiquity in the “lower” kingdoms, 
comparatively few instances of native CSSR are found in eukaryotes.   
 The products of SSR-mediated reactions are often dependant on the orientation of the 
DNA substrates. Linear recombination occurs in the event of a single cross-over between two 
independent linear DNA molecules, but in the event that one or both attachment sites lie on a 
circular DNA molecule, SSRs will mediate an integration reaction. Should two attachment 
sites be found on the same DNA molecule, a cognate SSR will facilitate either an excision or 
inversion reaction depending on whether the attachment sites are oriented head-to-tail or head-
to-head respectively (Nash, 1996).  
Cognate attachment sequences can be identical or non-identical depending on the particular 
SSR. Systems utilizing non-identical attachment sites (ex. λInt, fC31Int) are typically 
differentiated by using the terms attB (attachment-Bacteria) & attP (attachment-Phage) for the 
substrate sequences, and attL (attachment-Left) & attR (attachment-Right) for the product 
sequences. attL and attR refer to the standard orientation of the post-recombination sequences, 
one on the left (attL, upstream) of a GOI, the other on the right (attR, downstream). 
In the years since Campbell’s foundational 1962 paper, a plethora of Site-Specific 
Recombinases have since been discovered and characterized. These enzymes are nearly all 
partitioned into two classes based on their catalytic amino-acid residue: the Tyrosine 
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Recombinases (in the past referred to as the λ Integrase Family), and the Serine Recombinases 
(Grindley et al., 2006; Nunes-Düby, Kwon, Tirumalai, Ellenberger, & Landy, 1998). 
 
2.2  Tyrosine  Recombinases  
The Tyrosine Recombinases (TRs) are a diverse group of enzymes in terms of both origin and 
function. It was originally believed TRs were nearly exclusively found in prokaryotes, with 
the only eukaryotic example being from the species Saccharomyces cerevisiae (Chan, Liu, Ma, 
Jayaram, & Sau, 2013).  However, this was refuted by the discovery of TR-active 
retrotransposons in Dictyostelium discoideum, Panagrellus redivivus, and Phycomyces 
blakesleeanus (Poulter & Goodwin, 2005).  TRs perform a wide array of functions including 
controlling plasmid copy-number in S. cerevisiae, regulating the lysogenic vs lytic cycles of 
various phage, and resolving hairpin telomeres in E. coli phage N15 (Futcher, 1986; Ravin, 
2011; Volkert & Broach, 1986). Over 1300 TRs from bacterial genomes have been discovered. 
However, only a few well-characterized TRs will be discussed here (Houdt, Leplae, Lima-
mendez, Mergeay, & Toussaint, 2012). 
The first, and most thoroughly characterized, TR is λ Integrase (λInt). However, two other 
key TRs, Cre Recombinase from phage P1, and Flippase (FLP) from S. cerevisiae, have since 
been developed and are nearly, if not equally, as well characterized (Y. Chen & Rice, 2003a; 
Grindley et al., 2006). 
TRs are classified as such due to their use of a core tyrosine residue for catalysis. They also 
typically contain a highly conserved catalytic fold (Esposito & Scocca, 1997; Nunes-Düby et 
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al., 1998).  This fold consists of five residues: Arginine, Lysine, Histidine, Arginine, and either 
Histidine or Tryptophan (Gibb et al., 2010).  There is also evidence that a sixth conserved 
residue, Aspartic Acid/Glutamic Acid, indirectly stabilizes the catalytic site via additional 
hydrogen bonding (Gibb et al., 2010).  Some small TRs, such as FimE and FimB, consist of 
only this catalytic domain (Bryan et al., 2006).  However, small TRs such as these are 
uncommon. Most TRs contain at least one, if not multiple, auxiliary N-terminal domains to 
facilitate DNA binding.  
Formation of the synaptic complex begins with the binding of recombinase monomers to 
their cognate recognition sequences. They do so on each side of a central region in the 
attachment sequence, delineated by the scissile phosphates – approximately 6-8 bp apart. A set 
of four bound TRs bring the two DNA molecules together and form a tetrameric synaptic 
complex (Grindley et al., 2006). 
Strand exchange begins with single-strand cleavage of each DNA substrate, at their 
opposing scissile phosphates. This proceeds according to a type IB Topoisomerase mechanism, 
wherein the catalytic tyrosine performs a nucleophilic attack on a scissile phosphate, resulting 
in a 3’-phosphotyrosyl intermediate and a 5’-hydroxyl (Krogh & Shuman, 2000). Strands are 
exchanged within the synapse via the newly freed 5’ hydroxyls attacking their opposing 3’ 
phosphotyrosines, to form a Holliday junction intermediate. Of the four TRs in the tetrameric 
complex, only two are catalytically active at a time (Chen et al., 2000).  This necessitates the 
two-step strand-exchange process typical of TRs. The Holliday junction isomerizes to activate 
the inactive recombinase monomers, and the process repeats (Guo, Gopaul, & Duyne, 1997).  
While full scale recombination only occurs in the context of a tetrameric synapse, there is 
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evidence that TR dimers can in rare cases initiate strand cleavage on their own (Ghosh, Lau, 
Gupta, & Duyne, 2005). 
Highly conserved amino acid residues are expected to have important functional 
characteristics. Structural and mutational studies have elucidated some of these functions for 
the amino acids surrounding the nucleophilic tyrosine in the TR active site. The pair of 
immutable arginines (indexed 173 & 292 in Cre, 191 & 308 in FLP) are responsible for 
counteracting the negatively-charged non-bonding oxygens of the scissile DNA phosphate 
(Biswas et al., 2005; Gibb et al., 2010).  The active-site lysine stabilizes the 5’-hydroxyl moiety 
produced during strand cleavage (Ghosh, Lau, et al., 2005).  It has been observed in FLP that 
conserved histidine-305 operates in a basic fashion, drawing a proton from the core tyrosine, 
thereby priming it for the strand-cleavage reaction (Whiteson, Chen, Chopra, Raymond, & 
Rice, 2007).  The semi-conserved His/Trp residue may be involved in either hydrogen bonding 
with the cleaved 5’-hydroxyl, or positioning of the catalytic tyrosine via hydrophobic 
interactions, and these functions may vacillate based on the particular TR (Chen & Rice, 
2003b; Gibb et al., 2010; Ma, Kwiatek, Bolusani, Voziyanov, & Jayaram, 2007). 
An interesting point of diversity in the TRs emerges when studying the assembly of the 
enzymes’ active site. For most TRs (including λInt and Cre) , the active site is formed in a self-
contained fashion, wherein all key components of the catalytic fold originate from an 
individual recombinase monomer. However, in other TRs (such as FLP and R), the active site 
is assembled at the confluence of two recombinase molecules. Observations of these trans 
active sites show the inactive member of a recombinase pair donating a catalytic tyrosine to 
the active member (Gibb et al., 2010; Yang & Jayaram, 1994).  But despite these distinct 
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differences, the orientation of the catalytic tyrosine and sex associated auxiliary amino acids 
relative to one another is remarkably similar regardless of cis or trans assembly (Jayaram, 
1997). 
While some TRs, such as Cre and FLP, recombine two identical DNA binding regions, 
others such as λInt act on two distinct attachment sites. Nevertheless, it has long been 
understood that the core sequences directly recombined through the Holliday junction 
intermediate must be perfectly homologous. This homology promotes a stable intermediate, 
and in its absence the Holliday junction resolves to a prior stage or simply does not form at all 
(Joonsoo Lee & Jayaram, 1995; Nunes-Düby, Azaro, & Landy, 1995).  Recently, however, 
some examples of TRs bending the homology rule have been unearthed. The conjugative 
transposon CTnDOT, from Bacteroides, codes for a TR named IntDOT. IntDOT has a 
mechanism of action that results in crossover between 5 bp non-homologies, which are not 
resolved until further DNA replication takes place (Malanowska, Salyers, & Gardner, 2006).  
Filamentous bacteriophage CTXf eschews this convention in a slightly different manner. 
During integration into V. cholera, the phage’s ssDNA genome forms a forked hairpin wherein 
a 3 bp non-homology region occurs between two active sites, XerC and XerD. This non-
homology region prevents typical resolution of the Holliday junction, and the entire phage 
genome is then resolved into the host genome during DNA replication (Das, Martinez, 
Midonet, & Barre, 2013).  
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2.2.1  λ  Integrase  
λ Integrase is notable in the TR family for facilitating recombination between two distinct 
DNA attachment sites. The size and complexity of the attP site, 240 bp, is large when compared 
to other TRs. This large size is due to the presence of additional binding sites for both λInt as 
well as auxiliary proteins. In contrast, λ attB is only 21bp (Fogg, Colloms, Rosser, Stark, & 
Smith, 2014). 
λInt binds not only the regions immediately flanking the 7 bp site of recombination (the 
Core-type binding sites which interact with the λInt C-terminal domain (CTD)), but also to 5 
arm-type binding sites that bind with the λInt N-terminal domain (NTD). Interspersed between 
these Arm-type sites are loci for binding of 3 additional proteins: integrating host factor (IHF), 
Fis, and Xis (Landy, 1989) (Figure 1).  Binding of these co-factors are crucial in determining 
the efficacy and direction of recombination by λInt. 
No matter whether recombination is integrative or excisive, λInt is central to the reaction. 
λInt consists of two domains, C-terminal and N-terminal, with each domain having a distinct 
structure and role. The λInt CTD contains the catalytic tyrosine residue, and is responsible for 
binding to core-type regions of both attP and attB sites (Tirumalai, Healey, & Landy, 1997).  
This domain strongly resembles the structure of other TRs, such as Cre and Flp, but is not 
capable of facilitating recombination in the absence of the λInt NTD. It is, however capable of 
resolving previously constructed Holliday junctions (Dibyendu Sarkar et al., 2002; Tirumalai 
et al., 1997).  
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The λInt CTD can be further partitioned into a catalytic domain (responsible for providing 
the nucleophilic tyrosine 342) and a central binding domain that allows greater sequence 
specificity. These two sub-domains are connected via a 17 amino acid (aa) linker (Aihara, 
Kwon, Nunes-Düby, Landy, & Ellenberger, 2003).  Within the catalytic domain, the Tyr342 
is positioned away from the catalytic fold when unbound. However, during the formation of a 
Holliday junction, the Tyr342 moves 20 angstroms, into alignment with the catalytic fold 
(Aihara et al., 2003; Kwon, Tirumalai, Landy, & Ellenberger, 1997).  This shift coincides with 
an interprotomer conformational change wherein the b7 strand in the λInt CTD extends to 
interact with adjacent λInt CTD domains. Mutating or eliminating this region destroys 
recombination activity (Tekle et al., 2002). 
 
 
Figure 1 - λ attP Diagram 
Gene diagram of the λ attP region. P sites (arm-type sites) interact with λInt NTD binding domain, whereas 
C sites (core-type sites) are bound by the λInt core binding domain. H sites are bound by IHF, X sites by 
Xis, and F by Fis. Red indicates sites necessary for integration, Blue for excision, and Orange for both. The 
magenta region contains base pairs involved in the formation of the Holliday junction. Figure adapted from 
(Seah et al., 2014). NTD, N-Terminal Domain; IHF, Integrase Host Factor. 
 
The λInt NTD binds arm-type DNA regions via interactions between a three-stranded b-
sheet structure and the major groove of the arm-type region (Wojciak, Sarkar, Landy, & Clubb, 
2002).  This type of interaction bears strong similarity to other DNA-binding domains such as 
in Tn916 integrase, or GCC-box Binding Domain in Arabidopsis thaliana (Allen, Yamasaki, 
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Ohme-Takagi, Tateno, & Suzuki, 1998).  An 11 aa chain that precedes the b1 strand further 
stabilizes binding by interacting with the arm-type site minor groove, though is unstructured 
when not bound (Fadeev, Sam, & Clubb, 2009).  
Given that the presence of the λInt NTD is the most striking difference between λInt and its 
monovalent counterparts, its role in λ recombination is curious. A 2001 study found that, in an 
extremely counterintuitive result, λInt CTD exhibited increased levels of DNA binding  and 
topoisomerase activity in the absence of the NTD (Sarkar, Radman-Livaja, & Landy, 2001).  
The λInt NTD appears to counteract this shortcoming by providing λInt with its trait of 
directionality. Linking the λInt NTD to a Cre Recombinase was found to convert Cre from a 
bidirectional recombinase to a unidirectional one. Moreover, it allowed Cre functionality to be 
directly influenced by λ accessory proteins Integration Host Factor (IHF), Xis, and Fis 
(Warren, Laxmikanthan, & Landy, 2008). 
IHF is a host-coded heterodimeric protein required for successful λ recombination. While it 
serves a variety of roles in vivo, including contributions to gene regulation and DNA 
replication, its primary role in λ recombination is to control the 3-dimensional arrangement of 
the attP DNA (Ryan, Grimwade, Camara, Crooke, & Leonard, 2004; Sze, Laurie, & Shingler, 
2001).  Bending of the attP DNA allows λInt to properly bind to both core-type and arm-type 
binding regions, and even small changes in accuracy of this IHF-facilitated bending can 
drastically reduce recombination efficiency (Nunes-Düby, Smith-Mungo, & Landy, 1995). 
Xis is a phage-coded protein responsible for excessive recombination by λInt. Xis binds in 
triplicate to 3 closely spaced regions of attR titled X1, X1.5, and X2. Xis binding induces a 
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DNA bend of 72°. The distinct DNA topology produced by Xis binding, allows for tetrameric 
λInt formation despite the difference in DNA substrate sequences (attB/P vs attL/R) (Abbani 
et al., 2007). 
Fis, like IHF, is a host-encoded protein that helps control DNA orientation during λ 
recombination. Notably, it increases the efficacy of excisive recombination by up to 20 fold in 
situations where Xis concentration is low (Thompson, Vargas, Koch, Kahmann, & Landy, 
1987).  Conversely, excision drops by as much as 100 fold when Fis is absent (Papagiannis et 
al., 2007). 
 
 
Figure 2 – λ Recombination Topology 
λ integration takes place under precise topological constraints. Proteins such as IHF play a crucial role in 
mediating this DNA topology so that integrative recombination can take place. This diagram shows the 
DNA topology before and after recombination. The Holliday Junction (not shown here), occurs central to 
the 4 λInt monomers. Figure adapted from (Seah et al., 2014). IHF, Integrase Host Factor. 
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The interactions between these auxiliary proteins and λInt result in a complex and distinct 
topology of DNA and protein that facilitates recombination (Figure 2). 
The landmark application of λInt from a biotechnology or synthetic biology standpoint was 
the development of Gateway cloning. Gateway technology was first described in 2000, as a 
major advancement for in vitro cloning (Hartley, Temple, & Brasch, 2000).  The first 
component of this system is the Entry Vector, with a GOI flanked by orthogonal attL sites and 
a backbone coding for kanamycin resistance. The second component, the Destination Vector, 
contains the gene ccdB flanked by orthogonal attR sites and a backbone coding for ampicillin 
resistance (Hartley et al., 2000) (Figure 3).  The application of a solution containing λInt, IHF, 
and Xis, instigates the movement of the GOI from the Entry Vector to the Destination Vector 
via λ Recombination. The selection parameters, with differential backbone selection as well as 
counter selection by ccdB (a gene that results in E. coli death via double-stranded DNA 
breakage) allow for excellent cloning efficiency (Bernard & Couturier, 1992). 
This technology has since been leveraged to produce instances of multisite cloning, by 
chaining together orthogonal recombination sites, as well as instances where multiparallel 
expression libraries can be kept for both E. coli and S. cerevisiae (Cheo et al., 2004; Freuler, 
Stettler, Meyerhofer, Leder, & Mayr, 2008; Giuraniuc, MacPherson, & Saka, 2013). 
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Figure 3 – Gateway Cloning Diagram 
Gateway Cloning was one of the first industrially relevant uses for Site-Specific Recombinase technology. 
It allowed genes in a cloning library to be easily transferred to an expression library via the application of 
LR Clonase – a mixture containing λInt as well as all necessary auxiliary proteins. Figure adapted from 
(Hartley et al., 2000). 
 
2.2.2  Cre  Recombinase  
Over a decade after the discovery of λ Integrase, a new phage-derived recombinase was 
purified and characterized in phage P1 (Abremski & Hoess, 1984).  This recombinase was 
dubbed Cre, for Causes recombination. 
In contrast with phage λ, the genome of phage P1 does not integrate into the E. coli genome 
during a lysogenic phase. Instead, the linear P1 DNA circularizes via Cre-recombination and 
maintains itself as a low-copy plasmid within the host cell. Additionally, Cre is used to resolve 
topologically linked plasmids caused by replication of the viral DNA.  
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Cre binds to a single DNA locus, titled loxP. loxP is a 34 bp sequence consisting of a unique 
8 bp recombination region flanked by two 13 bp perfect inverted repeat regions (Table 1).  
Like all Tyrosine Recombinases, recombination occurs via a Holliday junction intermediate, 
with cleavage occurring at indices 14 and 20 of the loxP region (Hoess, Abremski, & Sternberg, 
1984). 
The structure of Cre has been elucidated through several crystal structures examined at 
various points through the Cre-loxP interaction process (Gibb et al., 2010; Guo et al., 1997; 
Martin, Pulido, Chu, Lechner, & Baldwin, 2002).  Cre can be split into two domains, a 130 aa 
N-terminal domain, and a 211 aa CTD. The former consists of five alpha-helices (A-E) 
involved in DNA binding, but not catalytic activity (Ghosh, Chi, Guo, Segall, & Van Duyne, 
2005).  In fact, Cre recombinase can maintain its function even when as many as 20 amino 
acids are eliminated from the NTD (Rongrong, Lixia, & Zhongping, 2005).  The C-terminal 
domain contains the entire conserved catalytic fold, including the central catalytic tyrosine 
residue which in Cre is indexed to amino acid 324.  
loxP binding initiates a C-clamp formation in Cre wherein the NTD binds to the major 
groove with helices B and D,  and the CTD binds both major and minor grooves on the 
opposing side. The interactions between the Cre protein and the loxP DNA are, in some cases, 
augmented by hydration effects (Baldwin et al., 2003). 
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Table 1 – Variations of the Cre-Lox System 
Directed evolution experiments have resulted in the development of several variants of the Cre-Lox pairing, 
in which the Cre amino-acid sequence and Lox base-pair sequences have been altered. Regions highlighted 
in red indicate involvement in a Holliday junction. 
Cre  Variant   Site  Name   Site  Sequence  
Cre   loxP   ATAACTTCGTATAATGTATGCTATACGAAGTTAT  
Fre   loxH   ATATATACGTATATAGACATATATACGTATATAT  
Cre2(+/-)#4   loxM7   ATAACTCTATATAATGTATGCTATATAGAGTTAT  
CRE-­‐R3M3   loxK2   GATACAACGTATATACCTTTCTATACGTTGTTTA  
Brec1   loxBTR   AACCCACTGCTTAAGCCTCAATAAAGCTTGCCTT  
 
 
Two Cre monomers will bind cooperatively to a loxP region, causing a 100° bend in the 
recombination region of loxP (Ennifar, Meyer, Buchholz, Stewart, & Suck, 2003).  
Subsequently, a tetrameric synapse is formed, bringing together 4 Cre and 2 loxP sites. The 
ensuing strand-exchange via Holliday junction takes place in a manner typical of the TR 
family.  
The Cre-Lox system began to grow in popularity as a tool for genetic engineering in 
mammalian cells, due to its efficiency and thermostability. It has been suggested that this 
efficiency is in part due to the highly stable synaptic conformation formed between Cre and 
loxP. The bound Cre-loxP conformation has a dissociation constant of 10 nM, though this 
stability is pH dependant and falls precipitously at pH values above 8.5 (Ghosh, Guo, & Van 
Duyne, 2007).  Cre recombinase shows optimal excision activity at 37°C, compared to a 
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recombinase like FLP which shows optimal excision at 30°C (Buchholz, Ringrose, Angrand, 
Rossi, & Stewart, 1996).  
In particular, the Cre-Lox system has been used extensively for in vivo gene-knockout 
experiments in mice. This protocol uses Cre recombinase in an excision reaction to eliminate 
genomic loci flanked by loxP sites, and has been used to study a wide variety of model 
biological functions including renal and cardiopulmonary disorders (Li et al., 2000; Rojek, 
Füchtbauer, Kwon, Frøkiaer, & Nielsen, 2006).  More recently, Cre-Lox technology has seen 
preliminary usage in pigs (Li et al., 2014). 
In an effort to expand the efficacy and functionality of the Cre-Lox system, numerous 
variants of the Cre-loxP pairing have been developed (Table 1). The first attempts at expanding 
the Cre toolbox used directed evolution to develop novel recombinase-DNA pairs. This 
resulted in the first variant, Fre-loxH, which differs from the wild-type by 4 nucleotides in the 
inverted repeats, as well as significant changes to the recombination region (Buchholz & 
Stewart, 2001).  Shortly after the development of Fre-loxH, came a third variant titled Cre2(+/-
)#4-loxM7 (Santoro & Schultz, 2002).  More recently, computational biology has made 
concerted engineering of recombinases attainable. By identifying 4 mutationally active regions 
a new Cre descendant was developed, titled Brec1-loxBTR. This particular recombinase may 
have implications for excising HIV-1 provirus in humans (Karpinski et al., 2016). 
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2.2.3  FLP  Recombinase  
The majority of industrially or academically useful recombinases are derived from phages, 
such as λ, P1, and fC31. Flippase (FLP) is one of the primary exceptions to this pattern, and 
furthermore is of the rare recombinases to be derived from a eukaryotic source: Saccharomyces 
cerevisiae. Wildtype FLP interacts with a region of DNA dubbed Flippase Recombination 
Target (FRT). The Flippase Recognition Target is a 34 bp sequence, consisting of a unique 
8bp recombination sequence, flanked by a set of 13 bp inverted repeats. This FRT sequence is 
sufficient for excision and inversion reactions, but it has been shown that integration protocols 
benefit greatly from duplicating one of the inverted repeats upstream of the recombination 
sequence (Lyznik, Rao, & Hodges, 1996).  Being a monovalent Tyrosine recombinase, FLP 
largely operates on the same mechanistic principles as Cre recombinase. 
The gene coding for Flippase was first identified as one of four genes found on the 2µ 
Plasmid in S. cerevisiae (Andrews, Proteau, Beatty, & Sadowski, 1985).  The 2µ Plasmid is a 
selfish genetic element, wherein none of its genes have been shown to provide a benefit to the 
yeast organism. Rather, the genes of the 2µ element are strictly concerned with replicating and 
partitioning the selfish plasmid during S phase of mitosis, and maintaining a non-disruptive 
plasmid copy number during S. cerevisiae’s resting stage (Chan et al., 2013).  Copy number of 
this plasmid typically holds between 40-60; increases above that can be deleterious and even 
lethal to the host cell (Chen, Reindle, & Johnson, 2005).  
The 2µ Plasmid replicates via a modified rolling circle mechanism, whereby part of the 
plasmid is inverted after DNA replication has begun resulting in replication forks that move in 
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the same direction (Figure 4).  The product of this is a large molecule that contains two full 
copies of the 2µ DNA that is then resolved into two distinct copies. Both of these reactions, 
the inversion and the resolution, are mediated by FLP and a corresponding set of parallel FRT 
sites on the 2µ Plasmid (Futcher, 1986). 
The FLP monomer, like Cre, consists of two discreet domains. The NTD (residues 1-107), 
shows no apparent structural similarities to the Cre NTD, but seems to provide a similar 
function. The C-Terminal Domain contains the catalytic fold, including the archetypic 
Tyrosine residue (Y343). The two domains are connected by Helix D, a 28 aa amphipathic 
region that serves to not only bridge the NTD and CTD, but also to help stabilize the synaptic 
complex during recombination by interacting with adjacent NTDs in the tetrameric form of 
FLP (Chen et al., 2000). 
FLP induces recombination with half-of-the-sites activity, wherein only two catalytic 
tyrosine residues are active at a time. A dual nucleophilic attack occurs via a type IB 
Topoisomerase mechanism, a Holliday Junction is formed, the junction isomerizes, a second 
dual nucleophilic attack occurs, and the junction is resolved via strand exchange. While this 
process seems identical to Cre Recombinase, there is one key aspect that differentiates Flippase 
from both Cre as well as all other well-characterized Tyrosine Recombinases. Within the 
synaptic complex, the catalytic Y343 residue is active in trans. Helix M (the location of Y343), 
is donated to an adjacent FLP monomer such that Y343 joins the catalytic fold of the adjacent 
monomer. Y343 residues that are inactive are seen to be disordered, and reside 10 angstroms 
away from their respective catalytic folds (Chen et al., 2000).  FLP appears to show no 
preference for order of strand exchange once recombination has commenced (Jehee Lee, 
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Tribble, & Jayaram, 2000).  The domain swapping of helices D and M helps ensure that the 
full synaptic complex is formed before any accidental nucleophilic attacks take place. It may 
also be beneficial should one FLP monomer become degraded partway through a reaction – 
another FLP monomer can help resolve it (Chan et al., 2013). 
 
 
 
Figure 4 - 2µ Plasmid Replication 
In its native state, FLP-FRT helps mediate replication of the 2µ plasmid. Typically, during DNA replication, 
the replication forks (red chevrons) move in opposite directions. By inducing site-specific recombination 
mid-replication, the 2µ plasmid is able to undergo rolling-circle replication wherein the replication forks 
move in concert with one another. Figure adapted from (Chan et al., 2013). 
 
 
FLP in its native form operates optimally at 30°C (Buchholz et al., 1996).  However, interest 
in using FLP in mammalian model organisms was high, and directed evolution of FLP soon 
led to a more thermostable protein called FLPe (e for eighth generation). Relative to wildtype 
FLP, FLPe shows 4-fold increased recombination efficiency at 37°C, and 10-fold increased 
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recombination efficiency at 40°C (Buchholz, Angrand, & Stewart, 1998).  A new variant, 
FLPo, has been developed that is codon-optimized for expression in mice. FLPo shows an 
order of magnitude increased efficiency relative to FLPe, and appears to be comparable to Cre 
Recombinase in mouse models (Raymond & Soriano, 2007).  The development of FLPo has 
allowed the FLP-FRT system to be utilized in gene knock-out/in experiments in not only 
mouse models, but porcine species as well (Kranz et al., 2010; Lin et al., 2015). 
Successful efforts have been made to orthogonalize the FLP-FRT system through directed 
evolution. These FLP variants bind to altered FRT sites, generically titled mFRT sequences. 
The initial development saw a single amino acid change in FLP (K82Y) result in preferential 
binding to sequence mFRT11 (Voziyanov, Stewart, & Jayaram, 2002).  Subsequent work 
would see a variety of mFRT sequences developed with substitutions ranging from 1-5bp 
(Voziyanov, Konieczka, Stewart, & Jayaram, 2003).  This allows multiple sites of 
recombination to be utilized by implementing combinations of FLP variants, reminiscent to 
the development of Fre-loxH from Cre-loxP (Konieczka, Paek, Jayaram, & Voziyanov, 2004).  
With the potential of developing novel FLP variants by directed evolution in mind, studies 
have begun to examine regions in the human genome that might be close enough to the native 
FRT sequence such that new Flippases could be developed to edit human DNA. In a 
preliminary study, over 600,000 regions show promise for such an endeavour (Shultz, 
Voziyanova, Konieczka, & Voziyanov, 2011). 
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2.3  Serine  Recombinases  
Five years after the isolation of λ Integrase, the study of bacterial transposon Tn3 uncovered 
a new protein with apparently similar function. Coded for by the tnpR gene, it took little time 
before it was realized that not only did this new recombinase have very distinct features relative 
to λInt, but that there were a large group of similarly featured enzymes (Heffron & Mccarthy, 
1979; Kostriken, Morita, & Heffron, 1981).  This family of enzymes would be named 
Resolvases, and the product of tnpR was dubbed Tn3 Resolvase (Plasterk, Brinkman, & Putte, 
1983).  A closely related recombinase from the γδ transposon (γδ Resolvase) became the 
archetypic member of this class when the mechanical distinctions between it and λInt were 
outlined in two 1981 papers by Reed and Grindley (Reed, 1981; Reed & Grindley, 1981).  
Shortly thereafter, it was observed that the enzymatic properties of this family were mediated 
principally by a conserved serine residue (Hatfull & Grindley, 1986; Reed & Moser, 1984).  
By the late 1990’s, it became common to divide the recombinases into two categories, the 
Tyrosine Recombinases, and the Serine Recombinases. It is now understood that within the 
Serine Recombinases are two subclasses: The Small Serine Recombinases (also referred to as 
the Resolvase/Invertase family), and the Large Serine Recombinases (LSRs; sometimes 
referred to as Serine Integrases).  
All Serine Recombinases (SRs) share a catalytically active core serine residue. Much like 
the TRs, there are a set of highly conserved amino acids that function within the SR active site 
(Grindley et al., 2006).  However, unlike the TRs, the entirety of the SR recombination domain 
retains a consistent size throughout the family. SRs are multi-domain proteins, and while all 
tautologically contain the SR catalytic domain, they vary drastically in their ancillary domains 
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(Smith & Thorpe, 2002).  It is, in fact, the variety and functional properties of these added 
domains that necessitates the distinction between the small and large families of SRs. The 
catalytic SR domain is nearly exclusively oriented at the N-terminus of the protein, though 
there is at least one example of a transposon coding an SR with a C-terminal catalytic domain 
(Kersulyte, Mukhopadhyay, Shirai, Nakazawa, & Berg, 2000). 
For the purposes of this review, and because much of the pioneering research on SRs was 
performed on γδ and Tn3 Resolvases, the SR catalytic domain will be discussed primarily 
through the lens of the Small Serine Recombinases. A later discussion of the LSRs and their 
unique structures and properties will follow. 
 
2.3.1  Small  Serine  Recombinases  (Resolvases/Invertases)  
The first SRs to be characterized (γδ and Tn3) functioned in the context of replicative 
transposition. The Tn3 transposon naturally forms a single cointegrant molecule during its 
replication. This cointegrant now contains two res recombination sites (the cognate binding 
sequence of Tn3 Resolvase). These res sequences allow for CSSR mediated by the Tn3 
resolvase, thus “resolving” the cointengrant into two separate molecules. 
Another well characterized member of the Small Serine Recombinases is the Salmonella 
enterica enzyme Hin. Hin, coded for by the eponymous hin, is a 190 aa invertase responsible 
for flagellar phase variation in S. enterica. By recombining two inverted imperfect palindromes 
(hixL and hixR), and thereby inverting the orientation of the SIGMA28 promoter, it effectively 
   28 
controls expression of two alternate flagellar proteins (Osuna, Lienau, & Hughes, 1995; 
Silverman & Simon, 1980). 
The γδ crystal structure was first published in 1990, and was further studied and refined in 
the following years (Rice & Steitz, 1994; Sanderson et al., 1990).  Each γδ monomer is 183 
amino acids long. The SR domain lies at the N-terminus, with a Helix-Turn-Helix (HTH) 
domain at the C-terminus. The two domains are connected by a short flexible linker peptide 
(Yang & Steitz, 1995).  The SR domain consists of a set of α-helices encircling a core β-sheet. 
An extended 36aa α-helix, the E-helix (αE), protrudes from the C-terminal side (Yang & Steitz, 
1995).  The N-terminal region of this E-helix allows for dimerization of γδ resolvase in 
solution. The 10 aa linker peptide connects the αE to the HTH domain, passing through the 
DNA minor groove when bound to its cognate substrate (Nollmann, He, Byron, & Stark, 2004).  
This characteristic SR domain structure is conserved across the SR family. 
The formation of the synaptic complex begins with γδ resolvase dimers binding to their 
associated res sequences. The C-terminal HTH domains bind along the major groove, each 
roughly 10 bp from the scissile phosphate. These domains are very likely uni-functional, given 
that an experiment replacing them with zinc-finger binding domains led to no change in 
recombinase function (Akopian, He, Boocock, & Stark, 2003).  Meanwhile, the C-terminal 
region of the E-helix helps position the catalytic region through minor-groove contact (Yang 
& Steitz, 1995).   
The synapse itself consists of two DNA res sites, and four SR units in a tetrameric formation. 
While these ingredients sound reminiscent of the TR synaptic complex, that is where the 
similarities end. The SR synapse is arranged with the DNA crossover regions on the outside, 
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with the SR tetramer bound together at the synapse core (Li, Kamtekar, Xiong, & Sarkis, 2005).  
While the full tetrameric crystal structure is now available, this synaptic formation had been 
suggested earlier when X-Ray diffraction data suggested significant separation of the DNA 
strands (Nollmann et al., 2004). 
Upon completion of the synaptic complex, each of the four SR units performs a nucleophilic 
attack via catalytic Serine-10, thereby covalently linking the recombinases to the 5’ ends of 
what are now four simultaneously broken strands (Reed & Grindley, 1981; Reed & Moser, 
1984).  This leaves each res sequence with a 2bp, 3’ overhang. From this arrangement, a 180˚ 
rotation is engaged between each half of the synapse (Stark, Sherratt, Soocock, & Gil, 1989; 
Wasserman, Dungan, & Cozzarelli, 1985).  This aligns the 5’-phosphoseryl moieties with the 
opposing 3’-hydroxyl groups, which then supplant the serine-10 residues, completing the 
recombination reaction. It is worth noting that the 2 bp overhangs are under strict conditions 
of homology; in the event that Watson-Crick pairing is unable to proceed, the synaptic complex 
performs a secondary rotation to realign the overhangs in their parental form. While this 
process prevents unwanted cross-over reactions, it interestingly imposes a new topology on the 
two DNA strands (Heichman, Moskowitz, & Johnson, 1991; Stark, Grindley, Hatfull, & 
Boocock, 1991). 
 
2.3.2  Large  Serine  Recombinases  
The Large Serine Recombinases (LSR) have a number of unique characteristics relative to 
the Resolvases, most notably their size. Where the smaller class of SRs are typically 180-200 
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amino acids long, the LSRs vary anywhere from 400-700 aa (Smith & Thorpe, 2002).  Whereas 
the resolvases are hosted equally by both gram-negative and gram-positive bacteria, the LSRs 
are found disproportionately more often in gram-positives (Mullany, Roberts, & Wang, 2002; 
Smith & Thorpe, 2002).  With respect to their role in the phage life cycle, LSRs function 
similarly to phage λ in E. coli. The recombinase protein allows for controlled integration and 
excision of the prophage into the host genome, allowing for strict regulation between the 
viruses lytic and lysogenic phases (Campbell, 1963).  However, in contrast with phage λ, the 
LSRs require no auxiliary binding proteins to facilitate integration and require only a single 
Recombination Directionality Factor (RDF) to catalyze the reverse reaction (Rutherford & 
Duyne, 2014). 
LSRs utilize the asymmetric attB/attP site specificity found in phage λ. In the wild, LSRs 
commonly, though not exclusively, integrate into intragenic attB sites. This often results in the 
silencing of the host gene, though in some cases the integrating DNA will contain translational 
signals to allow for continued gene expression such as during SSCmec mobilization in 
Staphylococcus (Misiura et al., 2013).  Table 2 provides a list of some of the best characterized 
LSRs and their wild-type locus of recombination.  
While many serine recombinases are produced by active bacteriophages, others are coded 
for by domesticated prophages. Examples of these include SpoIVCA in B. subtilis, A118 in L. 
monocytogenes, and LI Integrase in L. innocua (Kunkel, Losick, & Stragier, 1990; Loessner, 
Inman, & Lauer, 2000; Rutherford, Yuan, Perry, Sharp, & Duyne, 2013).  LI Integrase is of 
particular interest, as it was the first LSR to have a properly elucidated crystal structure 
(Rutherford et al., 2013). 
   31 
The N-terminal catalytic domain of the LSRs shares close homology with that of the 
Resolvase family. They exist as protein dimers in solution, but come together to form a 
tetrameric synaptic complex in the presence of their DNA binding sites (Ghosh, Pannunzio, & 
Hatfull, 2005).  And, just like the resolvases, elimination of the catalytic serine residue prevents 
recombination completely (Ghosh, Kim, & Hatfull, 2003; Smith, Till, & Smith, 2004). 
 
Table 2 - Origins and Hosts of Select LSRs 
The Large Serine Recombinases are derived from a wide variety of bacterial origins. A selection of these 
are listed, along with their native locus of integration. 
Host   Phage/Prophage   Locus  of  Integration   Reference  
M.  smegmatis   Bxb1   groEL1   (Kim  et  al.,  2003)  
S.  lividans   fC31   SCO3798   (Kuhstoss  &  Rao,  1991)  
S.  parvulus   R4   Acyl  Co-­‐A  synthetase   (Shirai,  Nara,  Sato,  Aida,  &  
Takahashi,  1991)  
M.  tuberculosis   fRv1   Rv1587c   (Bibb  &  Hatfull,  2002)  
S.  coelicolor   fBT1   SCO4848   (Gregory,  Till,  &  Smith,  2003)  
L.  innocua   LI  prophage   comK   (Rutherford  et  al.,  2013)  
  
 
What makes the LSRs clearly distinct from their smaller cousins is the presence of a large 
CTD of roughly 300-500 aa in size (Rutherford & Duyne, 2014).  The CTD is responsible for 
the high degree of sequence specificity exhibited by the LSRs, and is attached to the serine-
containing NTD by the αE (Ghosh et al., 2005; Singh, Ghosh, & Hatfull, 2013).  There are 
three discrete sub-domains within the CTD: a recombinase domain (RD) and a zinc-ribbon 
domain (ZD) which are connected by a short linker peptide, and a coiled-coil motif (CC) which 
emanates from the ZD (Rutherford et al., 2013).  While crystal structures are lacking for many 
LSRs, sequence comparisons between LI Integrase and other LSRs suggests the insights 
gleaned there are transferable to the LSR class in general (Rutherford et al., 2013). 
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When in contact with an appropriate attP site, each CTD subunit exhibits specific binding 
behaviours. The RD binds to the 13 bp immediately emanating from the core dinucleotide, 
whereas the ZD interacts with a smaller 9 bp motif, at a distance of 3bp outside the RD binding 
region. While the RD subunit will bind to the attP site in absence of the ZD, it does so with 
significantly less affinity (Ghosh et al., 2005; Mcewan, Rowley, & Smith, 2009).  Experiments 
using CC-deficient versions of LI Int have shown that the CC motif is not necessary for 
effective DNA binding (Rutherford et al., 2013). 
 
 
Figure 5 - LSR Recombination 
The Large Serene Recombinases eschew the Holliday junction found in the Tyrosine Recombinases. Instead, 
the tetrameric complex causes a staggered break in each DNA molecule and then rotates to create a new 
alignment. These fragments are re-ligated, to form the resultant attL and attR regions. Figure adapted from 
(Rutherford & Duyne, 2014). 
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This paradigm shifts slightly during LSR-attB binding. The ZD motif appears to be shifted 
5 bp towards the core dinucleotide (Rutherford et al., 2013).  This has two important 
ramifications: the ZD binding motif is spatially shifted by one half-turn, and now overlaps the 
RD binding region through a span of 2 bp. This shift appears to be present in other LSRs, 
including fBxB1 and fC31, and provides a strong explanation of why attB sequences are 
typically shorter than their attP counterparts (Gupta, Till, & Smith, 2007; Singh et al., 2013). 
 
2.3.3  fC31  Recombinase  
Streptomycetes have been medically interesting for more than 80 years, and have produced 
some of the most useful antibacterial and antifungal agents ever developed. But in the 1980s, 
the field of investigation expanded to include the viruses that are associated with the 
Streptomyces genus.  
Phage fC31 is a temperate virus that targets various members of Streptomyces, including 
S. lividans, S. ambifaciens, and S. coelicolor. fC31 is a double-stranded DNA virus. Its 
morphology consists of a polyhedral capsid with an associated elongated tail (Lomovskaya, 
Chater, & Mkrtumian, 1980).  The genome is 4.5 kb in size, with 63% GC content, and is 
linear-cohesive (Sinclair & Bibb, 1988).  Like all temperate phage, fC31 is capable of 
maintaining a lysogenic phase through prophage integration. While no crystal structure has yet 
been developed for fC31 Integrase, its close sequence similarity to LI Integrase suggest a 
nearly identical structure to its Listeria-sourced cousin discussed in section 2.3.2 (Rutherford 
et al., 2013). 
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Early biotechnological applications focussed on using engineered fC31 as a cloning tool 
for the Streptomyces platform. The characterization of the attP and attB sequences, as well as 
the first isolation of the fC31 Integrase would kick off the development of serine integrases as 
biotechnological tool for genetic engineering (Kuhstoss & Rao, 1991). 
The first demonstration of fC31Int as a tool for recombinant genetics came in 1998, when it 
was observed to facilitate cointegration between two plasmids both in vitro and in E. coli. 
Additionally, it was shown that fC31Int functionality was not constrained by the topology of 
its DNA substrates (Thorpe & Smith, 1998).  
After its performance in vitro, it was believed that fC31Int required no additional factors to 
facilitate attP/attB recombination. While this remains true of protein co-factors, it has been 
shown that trace levels of zinc are necessary for successful recombination. Pre-incubation of 
fC31Int with chelating agent EDTA prevented DNA binding by the protein. However, this 
phenotype was quickly restored by the addition of exogenous Zn2+ (McEwan, Raab, Kelly, 
Feldmann, & Smith, 2011). Additionally, zinc has also been shown to contribute to proper 
binding of fC31 Recombination Directionality Factor gp3 (Fogg et al., 2018). 
fC31 Integrase has become popular for a variety of synthetic biology applications 
involving gene integration and cassette exchange. Recombinase Mediated Cassette Exchange 
(RMCE) is a process wherein paired sets of attB and attP sites recombine in such a way that 
results in the interchange of the intergenic regions between them. RMCE via fC31 Integrase 
has been successfully demonstrated in bacterial platforms, such as Sinorhizobium meliloti, 
Ochrobactrum anthropi, and Agrobacterium tumefaciens (Heil, Cheng, & Charles, 2012).  In 
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insect cells, fC31 Integrase has been shown to mediate both standard integration events as well 
as RMCE events (Bateman, Lee, & Wu, 2006; Groth, Fish, Nusse, & Calos, 2004). Notably, 
fC31 Integrase was used to perform in vivo RMCE in Bombyx mori (a close cousin of 
Spodoptera frugiperda), resulting in the exchange of the reporter DsRed with EGFP in the B. 
mori genome (Long et al., 2013). 
 
2.4  Spodoptera  frugiperda  and  the  Sf9  Cell  Line  
Spodoptera frugiperda, colloquially known as the Fall Army Worm, is a small moth in the 
order Lepidoptera. It is common throughout eastern and central North America and is known 
predominantly for its role as a crop-destroying pest in the agricultural industry. However, in 
the biotechnology industry the species is most famous as the progenitor of the Sf21 and Sf9 
cell lines.  
By the mid-1970’s, a variety of insect cell lines had been established from both Lepidopteran 
sources (such as Trichoplusia ni) as well as Dipteran (such as Aedes aegypti) (Greene, 
Charney, Nichols, & Coriell, 1972; Hink, 1970).  In an effort to expand the repertoire of 
lepidopteran cultures, two preliminary cell-lines were established from S. frugiperda, initially 
titled IPLB-Sf-21, and IPLB-Sf-1254 (Vaughn et al., 1977).  These strains initially required a 
highly undefined media for growth, but IPLB-Sf-21 was soon modified through progressive 
adaptation to subsist on a medium devoid of Bovine Serum Albumin or Bombyx mori 
hemolymph (Gardiner & Stockdale, 1975).  This newly modified strain of S. frugiperda was 
titled IPLB-Sf-21-AE, or more commonly referred to as simply Sf21.  
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Tissue-derived lepidopteran cell lines are heterogenous in nature. This principle extends 
even to ploidy number, with the modal number of chromosomes sitting around 100 (Ennis & 
Sohi, 1976).  Individual cells in the Sf21 line vary in size, but average at roughly 19.5 um in 
diameter (Vaughn et al., 1977).  Progress made by Summers and Smith would help alleviate 
some of this heterogeneity by producing a clonal isolate of IPLB-Sf-21-AE, titled Sf9 
(Summers & Smith, 1987).  Along with Sf21, Sf9 would become a standard commercial 
offering in the field of insect cell culture, with Sf9 providing smaller more uniform cells and 
Sf21 providing slightly larger more variable cells (Invitrogen, 2002). 
Sf9 cells provide a versatile platform for biotechnological applications. They can be grown 
both adherently as well as in suspension and can be grown both in serum-free media as well as 
serum-supplemented media. They can be transitioned seamlessly between adherent and 
suspension settings. However, movement from serum to serum-free media requires an 
adaptation period of up to 7 days (Invitrogen, 2002).  Sf9 cells are grown optimally at 27°C, 
but will replicate comfortably in the range of 25°-30°C (Summers & Smith, 1987). 
The primary application of the Sf9 cell line is to provide a host for the Baculovirus 
Expression Vector System. While the BEVS is capable of providing extremely high levels of 
recombinant protein production, it suffers from the inherent drawback of killing the host Sf9 
cells. However, as early as 1990, there began research exploring the efficacy of using Sf9 as a 
platform for protein expression outside of the BEVS context (Jarvis, Fleming, Kovacs, 
Summers, & Guarino, 1990).  Results showed that under certain circumstances, transformed 
Sf9 cultures outperform infected Sf9 cultures. While b-galactosidase production was inferior 
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by a factor of 1000, production of human tissue-plasminogen activator (TPA) was on par with 
the BEVS alternative. Furthermore, TPA was processed more efficiently than in BEVS due to 
the Sf9 secretory pathway being uninhibited by Baculovirus infection (McCarroll & King, 
1997). 
Proteins that require specific post-translational modifications to achieve optimal activity, 
such as membrane receptors, may benefit from this expression environment. Expressed Chick 
Nicotinic Acytelcoline Receptor proteins, though present in lower quantity, were shown to 
have increased binding efficiency when expressed constitutively in Sf9 cells (Atkinson, 
Henderson, Hawes, & King, 1996).  In a more extreme example, Human b2-Adrenergic 
Receptor was found to be non-functional when expressed through BEVS, but was expressed 
successfully in a stably transformed Sf9 cell line (Kleymann et al., 1993).  Recombinant Factor 
C, natively produced in Limulus horseshoe crabs, was shown to be successfully expressed in 
Sf9 through stable transformation. The protein product was found to be fully functional, with 
84% being secreted into the culture supernatant (Wang, Ho, & Ding, 2001). 
G-Protein Coupled Receptors (GPCRs) are a class of proteins that exhibit a complex trans-
membrane folding pattern. This makes them difficult to produce accurately in heterologous 
expression systems. However, transformed Sf9 cells have shown promise in this area. Human 
µ Opiod Receptor was successfully expressed under constitutive OpIE2 control in Sf9 cells, 
producing 11,000-15,000 active receptors per cell (Kempf et al., 2002).  This result drastically 
outperformed production in yeast cells, and while  receptors were produced in much higher 
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peak quantities (20-fold higher) in HEK293 cells, the expression was not stable and waned 
quickly (Stanasila, Pattus, & Massotte, 1998). 
Stably transformed Sf9 cells are commonly pursued as an alternative to BEVS. However, 
they can also be used to compliment this system. Engineered strains of Baculovirus do not 
form occlusion bodies due to the elimination of their polh gene (they are genotypically occ-). 
Engineering of a host Sf9 line to independently produce polh during baculovirus infection 
successfully resulted in the production of phenotypically occ+, but genotypically occ-, 
baculoviruses (López, Alfonso, Carrillo, & Taboga, 2010).  These virions improve safety and 
increase the potential uses for in vivo implementations of Baculovirus expression systems 
where oral infection of larvae is required.  
Other host engineering efforts have focussed on extending the lifespan of an Sf9 cell through 
deferring apoptosis during Baculovirus infection. By the early 2000s, Campoletis sonorensis 
inchnovirus protein P-vank-1 had been shown to inhibit apoptotic processes in a variety of 
insect cells. In 2009 this technology was expanded to the Sf9 cell line. A recombinant line 
constitutively expressing P-vank-1 was shown to exhibit 5-fold increased viability relative to 
engineered Sf9, 5 days after infection with Baculovirus (Fath-Goodin, Kroemer, & Webb, 
2009).  Additionally, this line (titled VE-CLp1) was shown to have increased longevity under 
duress by UV radiation and camptothecin. The delay in cellular breakdown allows for the host 
cells to maintain their secretory pathway longer into the infection cycle. This results in 
improvements in both quantity and quality of protein produced in the BEVS-Sf9 system. VE-
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CL02 (a clonal isolate of VE-CLp1) was shown to produce 3x the protein yield vs control, as 
well as improved accuracy in post-translational processing (Steele et al., 2017). 
Of the promoters utilized by AcMNPV, only the IE1 promoter is active in uninfected 
Spodoptera cells (Jarvis et al., 1990).  However, efforts have been made to incorporate the 
later, stronger, AcMNPV promoters into the Sf9 genome. While not constitutively active, 
genomic implementations of the 39K, p6.9, and polh promoters can allow for host-expression 
of proteins in synchronicity with the Baculovirus infection cycle (Lin & Jarvis, 2013). 
 
2.4.1  Single  Cell  Isolation  by  Limiting  Dilution  
Given that locations of genomic integrations are difficult control, attempts to transform a 
monoclonal cell-culture for transgene expression typically result in a heterogeneous culture. In 
the case of insect cell culture, this eliminates many of the advantages of using Sf9 cells instead 
Sf21 cells. However, the clonal nature of a cell culture can be recouped through a procedure 
known as limiting dilution, which involves mechanically isolating individual cells from which 
a monoclonal culture is re-established. At its inception, limiting dilution used a statistical 
measure, Poisson’s distribution, to estimate the likelihood of a derived culture being clonally 
isolated; though with improvements in phase-contrast microscopy the statistical estimate is no 
longer necessary (Staszewski, 1984). Cells are aliquoted to a concentration of <1 cell/aliquot, 
and typically plated in 96-well tissue culture plates. (Gross et al., 2015) This extreme dilution 
inhibits growth by also resulting in a dearth of secreted growth factors for many cell species, 
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and often requires the application of specialized or conditioned media collected from cultures 
in exponential growth phase. (Gross et al., 2015) 
Isolating cells causes extreme stress, and results in high rates of cell death; it is reported that 
50-75% of isolated insect cells will die in a successful limiting dilution protocol (Rodrigues, 
Costa, Henriques, Azeredo, & Oliveira, 2014). While not all insect cell-lines are capable of 
surviving the limiting dilution protocol, examples of both the Sf9 and High-Five cell lines have 
been shown to be successful. (Steele et al., 2017; Vidigal, Fernandes, Coroadinha, Teixeira, & 
Alves, 2014)  The timeline for successful producing clonal isolates of a transformed Sf9 culture 
through limiting dilution has been clocked at between 2-4 months. (Rodrigues et al., 2014)  
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Chapter  3  
Design  Considerations  
As the field of molecular biology has progressed, the research community has developed 
an interest in building biological systems from an a priori standpoint. This has resulted in an 
exciting new field of synthetic biology. In an effort to further this type of approach, this project 
aimed to bring an element of engineering design to the Sf9 cell line.  
From the outset, the goal was to balance three primary elements: function, simplicity, and 
flexibility. For the final product, an RMCE-competent Sf9 cell line, to be most useful, it should 
provide efficient recombination with the least required number of steps (ex. transformations, 
selections) and be capable of facilitating as many types of experimental protocols as possible. 
The following section will address various design aspects and how they are balanced in the 
final genetic architecture.  
 
3.1  Considerations  on  Recombinase  Systems  
The first issue to be considered is which of the Site-Specific Recombinases should be 
central to this design. While dozens of recombinases/integrases have been identified, 
significantly fewer have been well-characterized and demonstrated as useful from a 
biotechnology standpoint. “Degree-of-characterization” is not a quantitative measure, and thus 
a somewhat arbitrary cut-off was necessary when determining which recombinases would be 
considered in the design phase; the initial list of recombinases consisted of λ Integrase, Cre 
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Recombinase, Flippase, and fC31 Integrase. After evaluating these recombinase systems on 
the criteria discussed in sections 3.1.1-3.1.3, fC31 Integrase was deemed to be the most 
promising for use in the Sf9 platform (Table 3). 
 
Table 3 - Evaluation of SSR Systems 
SSR   Simplicity   Orthogonality   Compatibility   Stability/Reversibility  
Lambda   +   +   +   +++  
Cre   +++   ++   +   +  
FLP   +++   ++   +++   +  
fC31   +++   +++   +++   +++  
 
 
3.1.1  Stability  and  Reversibility  
When genomic integration is the goal, the stability of integration is a key factor to consider. 
This hinges heavily on whether a recombinase system is reversible. In the cases of the Cre-
loxP and FLP-FRT systems, the product sequence formed upon recombination is identical, or 
near-identical, to the substrate sequence. This stems from the fact that the regions of 
recombination include inverted repeats. These systems are deemed to be reversible. 
Both the λ Integrase and fC31 systems operate by recombining two non-identical DNA 
sequences. Though the exact sequences differ for each system, these regions are termed attP 
and attB in both.  The resultant regions of DNA are distinct from their precursors. These 
product sequences, attL and attR, are not products for further recombination unless influenced 
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by a Recombination Directionality Factor (RDF). fC31 Integrase has a well-characterized 
RDF, gp3, that allosterically regulates the direction of recombination (Khaleel, Younger, 
Mcewan, Varghese, & Smith, 2011).  Because of this, they are deemed to be non-reversible 
recombination systems.  
Non-reversible recombination systems provide added stability when compared with 
reversible systems because they are not subject to secondary recombination reactions while the 
recombinase is active in the cell. Through the lens of reversibility, both the λ and fC31 
integrases provide an advantage over their compatriots.  
 
3.1.2  Orthogonality  
Recombinase Mediated Cassette Exchange (RMCE) is built on the principle of engaging 
multiple recombination reactions concurrently. One of the risks of this approach is the potential 
for crosstalk between recombination sites. This can result in a variety of unwanted results 
(Figure 6).  
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Figure 6 - Unwanted Results of RMCE 
A) In parallel orientation, both the GOI and the vector backbone can be feasibly integrated through RMCE. 
B) When att-sites are in reverse orientation, the GOI is guaranteed to be integrated, but the orientation of 
the integrated cassette cannot be controlled. GOI, Gene of Interest. 
 
In cases where the recombination sequences are identical, such as in Cre and FLP systems, 
genomic regions can react with themselves causing unwanted excision or inversion of the 
baseline region. If the system is one that requires non-identical recombination sites, the 
orientation of these sites can create ambiguity in the orientation of the integrated cassette or 
alternately result in risk of vector backbone integration.  
An orthogonal recombinase system is one in which the regions of recombination are 
incapable of engaging in unwanted crosstalk (i.e. Sequence A will only recombine with 
Sequence B, while Sequence C will only recombine with Sequence D). Orthogonality has been 
pursued with the development of recombinase variants (ex. Fre-loxH) as discussed previously, 
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but also with an approach called dual RMCE (often listed variously in the literature as dRMCE, 
or DICE for Dual Integrase Cassette Exchange). This approach sees the use of two separate 
recombinases simultaneously to achieve orthogonality. This technique was first developed by 
combining the use of Cre and FLPe in embryonic stem cells, and showed a recombination 
efficiency of 14%, 7-fold higher than a previously reported RMCE experiment using a 
heterospecific Cre-Lox pairing (Lauth, 2002).  This DICE approach appears to work in various 
formats provided the recombinases function in the host cell. It has been demonstrated 
successfully with Cre/fC31int pairing in mammalian DT40 cells, as well as with Cre/R pairing 
in tobacco plants (Dafhnis-Calas et al., 2005; Nanto & Ebinuma, 2008).  
 
 
Figure 7 - fC31 attP Core-Dinucleotide Variants 
In the fC31 attachment sequences, there is a two dinucleotide catalytic region. This results in 6 possible 
non-palindromic variations. Because proper Watson-Crick pairing is required for successful recombination, 
fC31-mediated RMCE can be made effectively orthogonal by utilizing different variations of these core-
dinucleotides. The standard attP sequence regions are highlighted in red, while the di-nucleotide variants 
are listed orthogonally in blue. RMCE, Recombinase Mediated Cassette Exchange. 
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While the DICE method provides orthogonality, much like evolved heterospecific 
recombinase pairs, they require an unfortunate increase in complexity from utilizing multiple 
recombinases simultaneously. The fC31 may have an advantage in this regard. Variants of the 
fC31 attP and attB sequences have been engineered that provide orthogonality without the 
need for concurrently evolved integrase proteins (Colloms et al., 2014).  Because the core 
dinucleotide involved in recombination is not responsible for binding specificity, but must 
nevertheless be identical for successful recombination, replacing this dinucleotide with any of 
the six possible variations creates an orthogonal system (Figure 7).  This provides a simple 
method of producing orthogonality within the confines of a single recombinase system, and 
shows no decrease in recombination efficiency with basic RMCE. The development by 
Colloms et al. makes the fC31 recombinase system particularly attractive. 
 
3.1.3  Compatibility  with  Sf9  Platform  
Regardless of any mechanistic advantages or disadvantages provided by a recombinase 
system, it must be operational in the context of the Sf9 cell line, which is cultured at 27°C. A 
crucial factor in this respect is the thermostability/active temperatures of these recombinases.  
Both Cre and λ Integrases are derived from E. coli phages, and so unsurprisingly they exhibit 
optimal activity at 37°C. Wildtype Flippase, in contrast, operates best at 30°C, and will 
completely denature by 38°C (Buchholz et al., 1996).  While successful efforts have been made 
to engineer FLP variants with peak activity at 37°C (FLPe, discussed previously), developing 
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variants of the E. coli phage integrases with low temperature activity has not been incentivized 
(Raymond & Soriano, 2007).  While there does not appear to have been any study specifically 
directed to determining optimal temperatures for fC31 Integrase activity, it is derived from 
Streptomyces phages which are cultured from 28-30°C (Shepherd, Kharel, Bosserman, & 
Rohr, 2010). 
Neither the λ nor the Cre recombinase systems have shown to be popular tools in insect 
platforms. In fact, Cre exhibited 0% transgene integration efficiency in both D. melanogaster 
and A. aegypti cells (Nimmo, Alphey, Meredith, & Eggleston, 2006).  In contrast, the same 
study found integration efficiencies of up to 31.8% in the same settings using fC31 Integrase. 
There do not appear to be any concerted studies examining the E. coli-phage-derived 
recombinases in the Sf9 platform specifically.  
Flippase has been utilized successfully in a variety of insect cell platforms, including the Sf9 
cell line. A strain of Sf9 was developed to facilitate transgene integrations using a FLP landing 
pad. While this study showed positive results, recombination efficiency was extremely low; 
the most successful trial showed ~100 successful recombination events per 106 transfected 
cells, while others showed as few as 5 per 106 cells (Fernandes et al., 2012).  Nevertheless, this 
technique was used to produce a stably transformed Sf9 culture producing rotavirus core-like 
particles (Fernandes et al., 2014).  Despite its low rate of efficiency for transgene integration 
in Sf9, FLP has shown stellar results when used for excision reactions in the closely related 
lepidoptera Bombyx mori. In vivo excision of a previously integrated (via piggyBAC) eGFP 
cassette flanked with FRT sites was shown to be as high as 97.1% (Long, Lu, & Hao, 2016). 
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The fC31 recombinase system has also been validated for use in the Sf9 platform. 
Chompoosri et al. used a lacZ assay to demonstrate plasmid-to-plasmid fC31 RMCE in the 
Sf9 cell line (Chompoosri et al., 2009).  This resulted in as many as 4100 successful exchange 
events per 106 cells, over an order of magnitude higher than the most successful trial in the 
Fernandes FLP cell-line. Nevertheless, it should be noted that this was a transient plasmid-to-
plasmid experiment and it is not guaranteed that this degree of efficiency would be seen in a 
genomic integration.  
While there has not been any genomic integration/RMCE events in Sf9 cells, there have been 
in B. mori. Single-site genomic integration was performed in a fC31-competent strain where 
in vivo integration efficiency was found to be 5.2% (Yonemura et al., 2013). Additionally, a 
full fC31-based RMCE competent line of B. mori showed successful in vivo exchange at a rate 
of 4.55% (Long et al., 2013). 
Most Tyrosine recombinases are not compatible with the culture conditions of a lepidopteran 
cell line. Although Flippase orchestrated RMCE has been developed for Sf9, the degree of 
success is questionable. The fC31 Integrase system, while less proven, shows obvious 
potential to out-perform FLP in the Sf9 platform. It also provides stable cassette exchange with 
structurally simple orthogonality.  
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3.2  Mistargeting  and  Pseudo-­attP  Sites  
One of the inherent risks involved with DNA editing is the potential for off-target effects. 
This occurs when an active recombinase binds to regions outside of its cognate binding site. 
Off-target effects can potentially have drastic deleterious effects to a cell, should an essential 
gene in the host cell be accidentally disrupted or excised. Locations of off-target integration 
are dubbed “pseudo-attP sites.” 
Off-target effects due to fC31Int implementation have been observed in S2 cells, though at 
very low levels (Groth et al., 2004).  Only 3 instances of pseudo-attP integration were reported 
in vitro, though precise efficiencies were not reported. These results were not replicated in 
vivo. A trial of fC31 Integrase mediated gene integration in human cells showed that pseudo-
attP sites within the human genome, though present and active, exhibited 8-17 fold fewer 
successful recombination events than a native attP site (Thyagarajan, Olivares, Hollis, 
Ginsburg, & Calos, 2001). 
While no similar studies have been performed in Sf9 cells, an alignment search of fC31 attP 
against the current published Sf9 genome suggests no regions bear more than 41% sequence 
identity (Figure E 1). This figure coincides with the identity levels reported in Groth et al. 
2004 mentioned previously, wherein low-level in vitro recombination occurred at pseudo-attP 
sites with 41% identity relative to a native attP site, and thus significant off-target effects by 
fC31Int are not expected to be problematic in Sf9. A trial of fC31 RMCE into the closely 
related lepidopteran species B. mori resulted in no pseudo-attP integration events (Long et al., 
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2013).  However, a promoter trap could be used to fully select against off-target integration 
(Figure 8). 
 
3.3  Selection  Markers  and  Reporters  
In the construction and operation of the proposed genetic system, selection markers are 
needed to ensure that the genomic cassette has successfully integrated into the Sf9 platform, 
as well as to isolate cells that have successfully exchanged cassettes after RMCE.    
Upon integration of the full construct in the Sf9 genome via piggyBAC (as discussed later), 
culturing in the presence of an antibiotic will provide a convenient avenue for selecting 
successful integrants. A variety of antibiotic selection markers have been shown to operate 
well in the Sf9 platform for the purposes of stable genomic integration, such as Hygromycin 
B, G418, Puromycin, and Zeocin (Douris et al., 2006). While all of these options are usable, a 
hygromycin resistance gene (Hygromycin phosphotransferase) CDS was included alongside 
the piggyBAC materials from Dr. Jarvis (University of Wyoming). Due to its availability, 
Hygromycin B was selected for use in this project. 
Promoter traps have been used to great effect in previous instances of RMCE (Fernandes et 
al., 2012). A methionine deficient selection marker can be implemented immediately following 
the cassette exchange region. This gene will remain inactive until a supplementary promoter 
and methionine are introduced, via cassette exchange, to activate antibiotic resistance (Figure 
8). To streamline the RMCE process, it is desirable to have a strong, rapid-acting selection 
scheme associated with this promoter trap. Puromycin and Blasticidin both allow for selection 
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protocols of one week or less, but Blasticidin is cost prohibitive; Puromycin was therefore 
selected for the promoter trap selection scheme (Thermo Fisher Scientific Inc., Mississauga 
ON).  
 
 
Figure 8 – Example Schematic of Promoter Trap 
A promoter trap allows selection for integration events at a specific pre-determined locus. In the donor 
plasmid, the GOI is flanked by a promoter and subsequent methionine codon. A methionine deficient 
selection marker within the genome (Puromycin in this case), is activated only when the integrating cassette 
lands immediately upstream of it. Puromycin resistance is not activated when the GOI lands elsewhere. GOI, 
Gene of Interest; pA, poly A sequence. 
 
To track the success of the Recombinase Mediated Cassette Exchange reaction, a reporter 
gene system can be used. The fC31 recombinase system was initially validated in Sf9 cells 
   52 
using a lacZ reporter, but this required transferring the donor plasmid back in to E. coli for 
verification (Chompoosri et al., 2009).  Fluorescent reporter proteins, such as those used in 
Fernandes et al. (2012) or Long et al. (2013), provide a convenient in vivo approach to tracking 
cassette exchange via flow cytometry (Fernandes et al., 2012; Long et al., 2013). 
While these fluorescent reporters would ideally never be co-expressed, a mixed culture of 
successful and unsuccessful recombinant Sf9 cells is a likely outcome post-treatment. 
Therefore, two fluorescent reporter genes with clearly differentiated emission peaks should be 
chosen. Additionally, the fluorescence intensity of each reporter should be balanced such that 
in a sample expressing both genes concurrently, both are easily detectable. A pool of 
monomeric fluorescent proteins already undergoing characterization in the Aucoin Lab was 
used as initial candidates (Table 4). mAzami-Green and mKOk were selected as candidates to 
be validated  through a co-transfection trial in vivo (Chapter 5). 
 
Table 4 - Flourescent Reporter Protein Candidates 
Flourescent reporter proteins considered for use in RMCE tracking. All proteins listed were being 
characterized in Aucoin Lab during the design phase of this thesis.  
Protein   Emmision  Peak  (nm)   AddGene  Reference  
mAzami-­‐Green   505   54798  
eGFP   507   13031  
mKOk   563   53617  
mKate2   633   37132  
LSSmKate2   605   31867  
mIFP   704   54620  
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3.4  Promoters  
Driving strong gene expression in the Sf9 cell line commonly relies on late-activated 
promoters from the AcMNPV, such as polh or p10. However, these viral promoters, central to 
the Baculovirus Expression Vector System, are only recognizable by their cognate viral 
polymerase. In the context of constitutive Sf9 expression, the early AcMNPV promoter IE1 is 
the BEVS-derived promoter of choice. This promoter has been in use extensively since it was 
first demonstrated to drive constitutive expression of tissue plasminogen activator in Sf9 cells 
(Jarvis et al., 1990).  The Immediate Early 1 promoter has since been central to various insect 
expression systems - most notably the InsectDirect system, a series of expression vectors that 
were shown to produce stable yields of protein kinase, heat shock protein, and phospholipase 
in Sf9 cells (Loomis et al., 2005).  Activity of the IE1 promoter can be improved with the 
upstream addition of an hr5 enhancer region (Ren et al., 2011). 
AcMNPV is not the only Baculoviridae member with promoters that function in lepidoptera. 
The Orgyia pseudotsugata Multicapsid Nucelopolyhedrosis Virus (OpMNPV) contains two 
early stage promoters, listed as OpIE1 and OpIE2, that natively perform similar roles to their 
AcMNPV counterparts (Theilmann & Stewart, 1992).  These promoters were first utilized in a 
recombinant setting during testing of the antibiotic Zeocin. During these early tests, the OpIE2 
promoter appeared to show 5-10 fold increased activity relative to OpIE1 (Pfeifer, Hegedus, 
Grigliatti, & Theilmann, 1997).  
The first direct comparison of these promoters showed that the enhanced IE1 promoter 
hr5IE1 provided a 20% advantage over OpIE2 during transient expression in Sf9 cells (Ren et 
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al., 2011).  However, a more recent study determined that over a longer timeframe (96h vs 
24h), OpIE2 showed a 3.3 fold increase in eGFP activity when compared to hr5IE1. This 
difference was even more pronounced when compared with other endogenous Spodoptera 
promoters (Bleckmann et al., 2015). 
Based on these reports, any of the Baculoviridae-derived promoters could be reasonably 
considered for use in a recombinant system based in the Sf9 cell line. For driving a key reporter 
gene the OpIE2 promoter appears to show the highest sustained output, and as such is the first 
choice for this design. 
 
3.5  Gene  Architecture  
After considering a variety of potential design choices, a gene architecture fulfilling all of 
the proposed guidelines was developed (Figure 9). This arrangement is composed of two 
major components. The first is a selection region for developing the target cell-line. This is 
composed of a hygromycin resistance gene flanked by FRT regions. The hygromycin 
resistance allows for selection for successful integrants while developing the cell-line. This 
gene is driven by an OpIE2 promoter, and aborted by the associated OpIE2 transcriptional 
terminator. The FRT regions provide a prospective laboratory with the option to remove this 
selection marker from the cell-line should it be so desired. FLP Recombinase’s natural 
predilection for excision makes it an optimal choice for this purpose.  
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Figure 9 - Gene Architecture 
Full diagram of the proposed recombinogenic gene architecture. Within the genomic landing pad region, 
there are three sub-cassettes with distinct functions. A Hygromycin resistance gene (HygR) is placed between 
two FRT loci. This selection marker allows the genomic cassette to be successfully integrated in the Sf9 
cell, while the FRT loci provide the option for its convenient removal if necessary. The fluorescent reporter 
mAG is placed between two orthogonal fC31 attP sites which form an RMCE landing pad. An ATG-
deficient puromycin resistance gene is used as a promoter trap, and is placed immediately following the 3’ 
attP site. When recombination occurs between the donor plasmid (expressing mKOk) and the genomic 
cassette, the result will be an Sf9 cell expression mKOk as well as expressing a now-active Puromycin 
resistance gene. This recombination event is mediated by a fC31 Integrase that is introduced via an 
expression vector that is co-transfected alongside the donor plasmid. Orthogonal att-sites are delineated by 
superscripts indicating their core-dinucleotides, tt and cc. 
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The second region is the area providing fC31-Recombinase Mediated Cassette Exchange 
functionality. A pair of fC31 attP sites are placed around a reporter gene. Placing attP sites in 
the genome is counterintuitive given that the natural lifecycle of Phage C31 sees the virus 
integrate into genomic attB sites. However, it has been shown in B. mori that RMCE between  
donor-attB and genomic-attP sites have a near 2-fold increase in success when compared to 
the reverse arrangement (Long et al., 2013).  The particular orthogonal attP sites are denoted 
attP-cc and attP-tt, based on their core dinucleotide. These particular core sequences were 
chosen to reduce any chance for misrecognition between sites.  
These fC31 attP sites flank a green fluorescent reporter gene, mAzamiGreen. Like the 
hygromycin resistance gene, the mAG CDS is driven by an OpIE2 promoter, and terminated 
by the OpIE2 3’ untranslated region (UTR).  
Immediately subsequent to the 3’ attP site, there sits a methionine deficient puromycin gene, 
followed by an OpIE2 transcriptional terminator. This promoter trap will allow for puromycin 
selection upon completion of RMCE by including a promoter and in-frame ATG at the end of 
the donor cassette.   
While Gibson Assembly has become the standard approach for bench-scale in vitro gene 
assembly, many labs still utilize restriction endonuclease techniques. In anticipating that this 
construct could potentially be shared with other research groups, restriction sites have been 
included flanking each functional gene such that different selection markers or reporters could 
be swapped in to facilitate another laboratory’s objectives. These sites were chosen to all be 6-
cutters or 8-cutters, and all are compatible with FastDigesttm restriction endonucleases. The 
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HindIII that is 5’ adjacent to the ATG- puromycin resistance gene was placed specifically to 
keep the Puror gene in frame after RMCE.  
The donor cassette consists of a red fluorescent reporter gene, mKOK, driven by an OpIE2 
promoter and terminated by the associated OpIE2 3’ UTR. Downstream of this 3’ UTR is 
another OpIE2 promoter with followed by a single methionine codon. Following RMCE, this 
region will activate the ATG- puromycin resistance present in the genomic cassette. These 
sequences are flanked by fC31 attB-cc and attB-tt sites, corresponding to the orthogonal attP 
sites on the genomic cassette.  
 
3.6  Implementation  
Developing the proposed strain of Sf9 first requires integrating the target cassette into the 
Sf9 genome. This can be facilitated by the use of piggyBAC transposon technology. The 
piggyBac transposon is a cut-and-paste transposon that is mediated by the enzyme piggyBac 
Transposase. The genetic component of piggyBac consists of two 13bp terminal inverted 
repeats and two 19bp subterminal inverted repeats, separated by 3bp on the 5’ side and 31bp 
on the 3’ side. These reside within less-stringently conserved regions of 311bp and 235bp 
respectively (Figure 10).  It inserts randomly into any TTAA tetranucleotide sequence (Elick, 
Bauser, & Fraser, 1996).  
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Figure 10 – piggyBac Transposon 
In its native form within T. ni, the piggyBac transposase gene (red) is flanked by two perfect terminal 
inverted repeats (blue, magenta), within larger semi-conserved regions (yellow). Shown here are the minimal 
forms of these TRDs. Figure adapted from (X. Li et al., 2005). TRD, Terminal Repeat Domain. 
 
 
PiggyBac technology is derived from the lepidopteran species T. ni, and has a long history 
of use in Spodoptera cell lines. After expression levels of genes introduced by piggyBac were 
seen to be subject to position effects, a set of altered piggyBac terminal repeat domains were 
developed to eliminate these effects (Shi et al., 2007).  This iteration of piggyBac technology 
has been successfully implemented in Sf9 cells to produce a variety of glycogene-expressing 
cell-line variants (Aumiller, Mabashi-Asazuma, Hillar, Shi, & Jarvis, 2012).  Developing the 
target strain of fC31-competent Sf9 cells is an ideal application of this piggyBac transposase. 
The target cassette will be placed in a piggyBac vector, and cotransfected with a piggyBac 
transposase into a culture of Sf9 cells. Successful integrants can be selected for via 
hygromycin.  
To favour integration events in transcriptionally active regions of the genome, a sterile run 
through a Flourescence-Activated Cell Sorter (FACS) could be used to filter out cells 
exhibiting low-levels of mAG expression. The resultant subculture of high-expressing 
integrants can be converted to a series of clonal isolates through a limiting dilution protocol. 
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Limiting dilution involves diluting cells and aliquoting them into tissue culture plates such that 
each plate-well contains a single cell. Adherent cultures grown up from each of these isolated 
cells can be considered genetically identical (Harrison & Jarvis, 2010). 
The final version of the proposed fC31-competent Sf9 cell line should exhibit a single locus 
of recombination. Thus, candidate strains produced through limiting dilution can be screened 
via qPCR to eliminate any isolates in which the piggyBac transposase caused multiple 
integration events. For single-integrant isolates, the location of integration within the Sf9 
genome can be determined through sequencing an inverse PCR. 
The remaining clonal isolate with the highest degree of mAG expression can then be tested 
as a fC31-competent Sf9 cell line. A co-transfection experiment involving the donor cassette 
and the fC31 Integrase on suicide vectors (plasmid vectors incapable of replication within the 
host cell) will confirm the functionality of this new cell-line. A successful trial will see post-
RMCE passages of the cell-line exhibit consistent expression of mKOK, as well as resistance 
to puromycin. 
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Chapter  4  
General  Materials  &  Methods  
4.1  Plasmids  Used  and  Constructed  
Table 5 - Plasmids Used & Constructed 
Name   Source   Description/Contents  
pJC2   Charles  Lab,  Waterloo,  ON   fC31  Integrase  CDS  
pBSII-­‐IE1-­‐orf   Jarvis  Lab,  Laramie,  WY   piggyBac  CDS,  IE1  promoter  
pIE1Hygro   Jarvis  Lab,  Laramie,  WY   Hygromycin  Resistance  CDS  
pXLBacII-­‐TetOnGG1-­‐DsRed1   Jarvis  Lab,  Laramie,  WY   piggyBac  TRD  forward  
pXLBacII-­‐TetOnGG57-­‐DsRed2   Jarvis  Lab,  Laramie,  WY   piggyBac  TRD  reverse  
pMTL85141   Aucoin  Lab,  Waterloo,  ON   Cloning  vector  
pOpIE2-­‐Csy4   Aucoin  Lab,  Waterloo,  ON   OpIE2  promoter/UTR  
pBsynbackbone001   Synthesized,  Thermo   Recombinatorial  backbone  
pMTL-­‐synbackbone   Constructed   Rec  backbone  in  cloning  
vector  
pMTL-­‐synbackbone-­‐Hygro   Constructed   Rec  backbone  +  Hygr  cassette  
in  cloning  vector    
pMTL-­‐synbackbone-­‐Hygro-­‐mAG   Constructed   Rec  backbone  +  Hygr  +  mAG  
cassettes  in  cloning  vector  
 
4.2  Bacterial  Maintenance  Protocols  
4.2.1  Overnight  Culture  and  Strain  Storage  
E. coli containing plasmids of interest were grown overnight in 25ml of LB broth at 37°C, 
shaken at 300rpm. The resultant overnight culture was then stored in 1ml aliquots, consisting 
of 85% culture and 15% glycerol, at -80°C. All E. coli used for cloning was strain DH5a. 
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4.2.2  Chemically  Competent  Cells  
The following was the standard procedure for making chemically competent E. coli DH5a 
cells. Volumes can be adjusted proportionally if needed. 
A 300ml flask of LB broth was inoculated with 3ml of overnight E. coli DH5a culture, at 
37°C, 235rpm, and incubated until cell density reached OD600=0.35. Once an optimal cell 
density was achieved the culture flask was placed on ice for 30 minutes, with occasional 
agitation. The culture was aliquoted evenly into 6 pre-chilled Falcontm 50ml Conical 
Centrifuge Tubes (Fisher Scientific Ltd., Ottawa, ON), and pelleted at 3000g for 15 minutes 
in a 4°C centrifuge. Supernatant was then decanted, and cell pellets were gently resuspended 
in in 30ml of ice-cold 100mM MgCl2. 
Cultures were consolidated down from 6 tubes to 4 and pelleted at 2000g for 15 minutes at 
2°C. The supernatant was decanted, and cell pellets were gently resuspended in 50ml of ice-
cold 100mM CaCl2. Cultures were incubated on ice for 45-60 minutes. After incubation, 
cultures were once again pelleted at 2000g for 15 minutes in a 2°C centrifuge. The supernatant 
was decanted and cell pellets were gently resuspended in 20ml of ice-cold 85mM CaCl2, 15% 
glycerol.  
Cultures were consolidated down from 4 tubes to 2, and pelleted at 2000g for 15 minutes in 
a 2°C centrifuge. Supernatant was decanted, and cell pellets were gently resuspended in 1ml 
of 85mM CaCl2, 15% glycerol. Cultures were pipetted in 50µl aliquots into pre-chilled 1.5ml 
microfuge tubes, and stored at -80°C. 
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4.2.3  Bacterial  Transformations  
Chemically competent E. coli cell preps were placed on ice. 5µl of plasmid-buffer solution 
was added to each competent cell prep, gently mixed, and incubated on ice for 40 minutes. 
Cells were heat-shocked in a 42°C water bath for 45 seconds, and then immediately incubated 
on ice for 2 minutes. 950µl of SOC media was then added into each transformation prep. 
Transformations were incubated for 1 hour at 37°C, 275rpm. 50µl, 100µl, and 500µl volumes 
were plated on LB agar (imbued with relevant antibiotic as necessary). Plates were incubated 
overnight at 37°C, and then inspected for colony growth.  
4.2.4  Miniprepping  Transformed  Plasmids  
Minipreps were performed using a GeneJETtm MiniPrep kit (Thermo Fisher Scientific Inc., 
Mississauga ON). All actions taken during miniprepping were done in accordance with the 
manufacturer’s protocols. 
 
4.3  DNA  Manipulation  Protocols  
4.3.1  PCR  &  Primer  Design  
Primers for PCR were designed with Benchling’s Primer Wizard (Benchling Inc., 
www.benchling.com) algorithm when possible. If the Primer Wizard algorithm was 
unsuccessful in selecting primers, primers would be designed manually within the Benchling 
sequence editor by analyzing the properties of surrounding DNA relative to the GOI. Primers 
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were always designed such that their Tm values were within 5°C of one another. Whenever 
possible, primers were designed with a 3’ terminal G or C clamp. 
Primers were ordered from Integrated DNA Technologies Inc. Primers were received as 
individual lyophilized samples. Samples were resuspended in dH2O at a concentration of 
200µM, and stored at -40°C. 
PCR reaction were carried out at 50µl volumes, using Phusion Polymerase and Phusion HF 
Buffer (Thermo Fisher Scientific Inc., Mississauga ON) (Table D 1).  Annealing temperatures 
were calculated using the NEB Tm Calculator v.1.9.10 (New England Biolabs Inc., 
tmcalculator.neb.com). Elongation times were based on a 45sec/kb heuristic, with a minimum 
time of 1 minute. Template plasmids were diluted 1/20 when necessary. PCR reactions were 
run for a standard 35 cycles. Products were analyzed on and extracted from an agarose gel. 
 
4.3.2  Splicing  Overlap  Extension  –  Polymerase  Chain  Reaction  
Splicing Overlap Extension – Polymerase Chain Reaction (SOE-PCR) protocols were 
performed in two 25µl mixes, for a total of 50µl (Table D 2). Annealing temperatures for both 
the overlap region and the outer primers were calculated using the NEB Tm Calculator 
v.1.9.10. Template fragments were included in roughly equimolar amounts; volumes were 
adjusted based on concentration. 
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Mix A would be run for 10 cycles, and then halted at 10°C. Mix B would be added into Mix 
A, gently mixed via pipette, and the combination would be run for a full 35 cycle PCR 
schedule. Products would be analyzed on and extracted from an agarose gel.  
 
4.3.3  Gibson  Assembly  
Fragments of interest were prepared by via PCR with Gibson primers. Gibson primers were 
designed using Benchling’s Gibson Assembly Wizard algorithm. Gibson reactions were 
performed in 10µl volumes using NEB Gibson Assembly Master Mix (New England Biolabs 
Ltd., Whitby ON). A total of 0.1pmol of DNA was used, with a 2:1 ratio of insert fragment to 
backbone fragment (Table D 3).  Volumes were adjusted based on size and concentration of 
DNA fragments. Components were combined and incubated for 1 hour at 50°C. Product was 
transformed according to section 4.1.3.  
 
4.3.4  Restriction  Cloning  
Restriction reactions utilized Thermo FastDigest enzymes, and the associated FastDigest 
Green buffer (Thermo Fisher Scientific Inc., Mississauga ON). ~1µg of DNA was used for 
each reaction (Table D 4).  Components were combined, gently mixed via pipette, and allowed 
to incubate at 37°C for 5 minutes. Resultant fragments were analyzed and extracted on an 
agarose gel. 
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Ligation reactions were performed at 20µl volumes, using T4 DNA Ligase in Thermo 10x 
T4 Buffer (Thermo Fisher Scientific Inc., Mississauga ON). Insert and backbone fragments 
were included at a 3:1 molar ratio (Table D 5).  Components were combined, mixed via pipette, 
and allowed to incubate overnight at 4°C. Products were transformed according to section 
4.1.3. 
 
4.3.5  Agarose  Gel  Electrophoresis  
Agarose gels were made at volumes of 50ml. For most applications, an agarose content of 
0.8% w/v was used. However, sometimes small fragments would be run on a 1.4% w/v gel. 
iNtRON RedSafe Dye (iNtRON Biotechnology Inc., Burlington MA) was utilized for DNA 
visualization ( 
Table D 6).  Electrophoresis was run for 1 hour, at 90V/300W/3A. Samples were prepared 
in 50µl volumes, with the addition of 8µl Thermo 6x Loading Dye (Thermo Fisher Scientific 
Inc., Mississauga ON), and run against a GeneRulertm 1Kb DNA Ladder or a GeneRulertm 
100bp DNA Ladder (Thermo Fisher Scientific Inc., Mississauga ON) (Figure 11). When 
extraction was necessary, samples would be run in parallel lanes, with a diagnostic lane 
containing 8µl, and an extraction lane with 50µl. Gels were lit with UV-B radiation using a 
Life Technologies TFX-35M Illuminator. 
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Figure 11 - DNA Ladders 
GeneRulertm 100bp DNA Ladder and GeneRulertm 1Kb DNA Ladder were used for DNA fragment size 
comparison during electrophoresis.  
 
DNA bands of interest were cut out of the gel and chemically extracted. Gel extractions were 
performed using a Thermo Scientific GeneJET Gel Extraction Kit (Thermo Fisher Scientific 
Inc., Mississauga ON). All actions taken during miniprepping were done in accordance with 
the manufacturer’s protocols. 
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4.3.6  DNA  Sequencing    
DNA sequencing was performed at The Centre for Applied Genomics (SickKids, Toronto 
ON). Sequencing primers were designed in Benchling (Benchling Inc., www.benchling.com). 
Samples were prepared in 7µl aliquots at a concentration of 0.05pmol-0.15pmol. 0.7µl of a 
sequencing primer, at a concentration of ~5pmol was added, for a total sample volume of 7.7µl. 
Samples were labeled and shipped in PCR tubes, further sealed in a Ziploc bag.  
 
4.4  Maintanance  of  Sf9  Cells  
Sf9 cells are grown in SF900-III media (Thermo Fisher Scientific Inc., Mississauga ON). 
They are maintained in shake flasks at 27°C and agitated at 130rpm. Cells were passaged when 
cell density reached 3-5x106 cells/ml, and were seeded down to 0.5x106 cells/ml. 
 
4.5  Flow  Cytometry  
To prepare samples for flow cytometry analysis, cells were mechanically detached from 
plates via gentle repeated aspiration. Samples were then spun down for 5 minutes at 150xG 
and the supernatant removed. The cell pellet was resuspended in 500µl of a 2% formaldehyde 
solution and set aside for 1 hour. Samples were subsequently transferred into 5ml round bottom 
test tubes and diluted with 2ml of PBS buffer.  
Samples were run on a FACScalibur flow cytometer, with 10,000 events collected per 
sample. Data was collected via the FL1-H (530nm) and FL2-H (585nm) emission filters. 
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Chapter  5  
Validating  mAG  and  mKOk  as  Reporter  Genes  
Based on a previous examination of emission frequency and intensity of several fluorescent 
proteins, it was believed that mAzamiGreen and mKOk would function well as a GFP/RFP 
pairing for testing the fC31-competent Sf9 cell line. To confirm that these reporters would 
function concurrently in the Sf9 line, a series of transfections were performed and analyzed via 
flow cytometry. Two plasmids, expressing mAG and mKOk respectively, were transfected 
individually, as well as co-transfected, into preparations of Sf9 cells. Data for each of these 
treatments, along with a 4th treatment consisting of a mixture of individually transfected cells, 
were collected using a FACSCalibur Flow Cytometer (BD Biosciences Inc., Mississauga ON). 
The FACSCalibur possesses a single 15 milliwatt argon-ion excitation laser with a wavelength 
of 488nm. It has 3 bandpass fluorescence detectors, with filter peaks at 530nm, 585nm, and 
670nm (Biosciences, 2010). 
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5.1  Materials  and  Methods  
5.1.1  Transfection  of  Sf9  Cells    
5x105 Sf9 cells were taken from suspension culture and plated into each well of a 6-well 
tissue culture plate. Cells were incubated for 2 hours to allow for attachment.  
Initial samples of mAG and mKOk plasmids were obtained from Aucoin Lab (University 
of Waterloo). Samples were thawed on ice from a -40°C storage freezer. They were measured 
via nanodrop to be at 411 ng/µl and 496 ng/µl respectively. Preparations of 1µg and 2µg of 
each plasmid were diluted in dH2O to a total volume of 100µl each. Preparations of 8µl of 
Escort IV Transfection Reagent (Sigma-Aldrich Canada Co., Oakville ON), a liposome-
forming mixture, was diluted in 92µl of SF900III media, for a total volume of 100µl. DNA 
solutions were mixed with transfection reagent solutions and allowed to incubate at room 
temperature for 60 minutes. 
After incubation of cells was complete, liquid media was aspirated from each well and 
replaced with 800µl of fresh SF900III media. 200µl of transfection mixture was added to each 
well, for a total volume of 1000µl. Plates were then incubated for 48 hours at 27°C. Samples 
were analyzed by flow cytometry according to section 4.4. 
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5.2  Results  
Three transfection permutations were explored: 
1.   mAzamiGreen (a green-fluorescent monomer) 
2.   mKOk (a red-flourescent monomer) 
3.   Co-transfection with both mAzamiGreen and mKOk 
Each of these was performed via transfection with 1µg of plasmid (Figure 12), and 2µg of 
plasmid (Figure 13). Additionally, a post-transfection mixture of 2µg transfections with mAG 
and mKOk was included in cytometric analysis (Figure 13). 
Data presented has been pre-gated to eliminate untransfected cells. Visual gates delineating 
treatment populations are labelled, mAG, mKOk, and mAG+mKOk. These labels include the 
percentage of data points found within the defined region. All plots are presented on log-log 
axes. Total Cell Count (TCC) for each plot is specified in the captions. 
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Figure 12 - Fluorescence Response of Sf9 Cells Transfected with 1µg of Plasmid 
A) Individual mAG transfection. TCC = 6467.  B) Individual mKOk transfection. TCC = 444.   
C) Co-Transfection with 0.5µg each of a mAG and mKOk plasmid. TCC = 3313. 
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Figure 13 – Fluorescence Response of Sf9 Cells Transfected with 2µg of Plasmid 
A) Individual mAG transfection. TCC = 5316.  B) Individual mKOk transfection. TCC = 347.  C) Mixture 
of cells individually transfected with mAG and mKOk. TCC = 3514.  D) Co-transfection with 1µg each of 
mAG and mKOk. TCC = 3848 
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5.3  Discussion  
The efficacy of a fluorescent reporter pair hinges on whether a transfected population of cells 
can be easily differentiated via flow cytometry or FACS. If non-overlapping flow cytometry 
gates can be produced whereby little-to-no data points from one treatment are present in a 
competing gate, the reporter pair can be deemed useful. For mAG and mKOk, this appears to 
be the case. 
In both instances of a singular mKOk transfection (Figure 12B, Figure 13B), 0% of points 
were present in the competing gates.  Singular transfection of mAG (Figure 12A, Figure 13A) 
found no bleed into the mKOk region, and trivial bleed into the mAG+mKOk region. This is 
an expected finding, given the reported difference in these two protein’s fluorescent emission 
peaks. It is worth noting, however, that significantly fewer total events showed mKOk 
expression relative to mAG expression. A longer incubation period may help mitigate this, by 
allowing greater build-up of mKOk proteins within the cell.  
In a future clonally-isolated RMCE-competent cell-line, expression of one of these proteins 
will be exchanged for the other. While the promoter trap function of the proposed design will 
ideally eliminate any unsuccessful RMCE-events, it may be necessary to sort these out through 
FACS. Figure 13C, a post-transfection mixture of the singular mAG and mKOk populations, 
mimics the result of a partially-successful RMCE reaction and shows that successful and 
unsuccessful reactions will be easily differentiable.  
In the proposed RMCE-competent Sf9 cell line, co-expression of these two proteins is an 
undesired outcome, and should also be sorted out of a post-RMCE population. While mKOk 
and mAG have significantly different peaks, mAG displays over twice the emission intensity 
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of mKOk. Prior to this experiment, it was unclear if fluorescence by mKOk would be strong 
enough to push the co-transfected population far enough away from the singular mAG 
population to be clearly distinguishable. In both Figure 12C and Figure 13D, less than 1% of 
events from the co-transfection were present in the mAG region. Furthermore, an overlay of 
all transfection data qualitatively shows that all three expression profiles are clearly distinct 
(Figure 14).  Based on these data, the use of mAzamiGreen and mKOk as a fluorescent reporter 
pair for use in testing an RMCE-competent cell line has been validated. 
 
Figure 14 – Composite Fluorescence Response of All mAG, mKOk Transfections 
An overlay of all cytometry data collected. Includes both 1µg and 2µg transfections. TCC = 23,249. 
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Chapter  6  
Construction  of  Target  Cassette  
The proposed genetic system involves several distinct gene cassettes that need to work in 
concert. To construct the full system, sub-cassettes coding for each ORF would be constructed, 
and then assembled together in context with the recombinase attachment sites and piggyBAC 
regions (Figure 15). 
Firstly, a “recombinatorial backbone” was synthesized as a gblock fragment through IDT 
Inc. This fragment contained a pair of FRT sites, as well as orthogonal attB and attP pairs, with 
restriction endonuclease sites interjected in between them (Figure 16).  The region containing 
the FRT sites and attP sites were PCR’d out to be used in constructing the genomic cassette, 
while the region containing the attB sites was separated for the donor cassette. 
Three sub-cassettes were constructed using PCR to isolate their component parts, and an 
SOE-PCR protocol was utilized to assemble them. These cassettes are the hygromycin 
resistance cassette, the mAzamiGreen cassette, and the puromycin promoter trap cassette. 
Once these sub-cassettes were constructed, both Gibson assembly and restriction cloning 
protocols were used to merge them with the recombinatorial backbone.  
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Figure 15 – Gene Construction Overview 
A) Individual gene fragments (promoters, CDSs, 3’ UTR sequences) are sourced and isolated via PCR. 
These gene fragments are then stitched together using an SOE-PCR protocol to produce sub-cassettes.  B) 
A “recombinatorial backbone”, PBsynbackbone001, containing recombinase attachment sequences is 
synthesized, and the sub-cassettes are integrated via Gibson assembly. The full cassette is placed between a 
set of piggyBac terminal repeat domain regions, for later integration into the Sf9 genome. CDS, Coding 
Sequences; SOE-PCR, Splicing by Overlap Extension Polymerase Chain Reaction; OpIE2-P, OpIE2 
promoter; OpIE2-T, OpIE2 transcriptional terminator; HygR, Hygromycin resistance coding sequence; 
mAG, mAzamiGreen coding sequence; PuroR, Puromycin resistance coding sequence. 
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Figure 16 – Diagram of Recombinatorial Backbone 
The recombinatorial backbone is a synthesized DNA fragment containing all the necessary recombinase 
attachment sites, along with intermittent restriction endonuclease recognition sites to provide the option 
restriction-cloning. This fragment is separated into the genomic component (containing the FRT and attP 
sites) and a donor component (containing the attB sites). 
 
 
PiggyBAC Terminal Repeat Domain (TRD) sequences and sequence for the piggyBac 
Transposase CDS were obtained courtesy of Dr. Donald Jarvis (University of Wyoming). The 
piggyBac Transposase CDS was subsequently codon-optimized for expression in Sf9 cells, 
and synthesized under control of the AcMNPV IE1 promoter. Synthesis of this CDS was 
performed via Thermo Fisher GeneArt (Thermo Fisher Scientific Inc., Mississauga ON).  
  
6.1  Methodology  and  Results  
6.1.1  Constructing  Sub-­Cassettes  
Promoter sequences, CDS’s, and transcriptional terminators required for the genomic 
cassette were isolated from plasmids via PCR as described in section 3.8.1 (Table 6).  Primers 
used for fragment isolation included overlapping overhang regions to facilitate subsequent 
SOE-PCR reactions. The promoter and terminator fragments were amplified multiple times 
using different primer overhangs to allow for use in multiple different SOE-PCRs. DNA 
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fragments are commonly labeled using the primers used in their creation (ex. PBpr007-008 is 
the fragment produced using primers PBpr007 and PBpr008). Fragments referenced in this 
chapter can be found in Table 7. 
 
Table 6 - Source Plasmids 
Component   Plasmid   Source  
OpIE2  Promoter   pOpIE2-­‐Csy4   Aucoin  Lab  
OpIE2  Terminator   pOpIE2-­‐Csy4   Aucoin  Lab  
Hygr  CDS   pIE1Hygro   Dr.  Donald  Jarvis  (Hollister,  Shaper,  &  Jarvis,  
1998)  
Puror  CDS   pOpIE2-­‐Csy4   Aucoin  Lab  
mAzamiGreen  CDS   pmAzamiGreen-­‐N1   Dr.  Michael  Davidson  (Addgene  #54798)  
(Karasawa,  Araki,  Yamamoto-­‐Hino,  &  
Miyawaki,  2003)  
 
 
Fragments PBpr001-002 (OpIE2 Promoter), PBpr003-004 (Hygr), and PBpr005-006 (OpIE2 
Terminator), were isolated via PCR from their respective sources. They were used in two 
sequential SOE-PCR reactions in an attempt to construct a full Hygr expression cassette. The 
first reaction, merging PBpr001-002 and PBpr003-004 was successful (Figure 17).  However, 
the subsequent attempt to merge this new fragment (PBpr001-004) with the 3’ UTR resulted 
in an erroneous band size (Figure 18, Figure B 1). 
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Table 7 - Constructed DNA Fragments 
Fragment   Description  
PBpr001-­‐002   OpIE2  promoter  with  5'  MfeI  site  
PBpr003-­‐004   HygR  CDS  
PBpr005-­‐006   OpIE2  3’  UTR  Transcriptional  Terminator  with  3'  NheI  site  
PBpr007-­‐008   OpIE2  promoter  with  5'  BamHI  site  
PBpr009-­‐010   mAG  CDS  
PBpr011-­‐012   OpIE2  3’  UTR  Transcriptional  Terminator  with  3'  SbfI  site  
PBpr013-­‐014   ATG-­‐  PuroR  CDS  with  5'  HindIII  site  
PBpr015-­‐016   OpIE2  3’  UTR  Transcriptional  Terminator  with  3'  NotI  site  
PBpr001-­‐004   OpIE2  promoter/HygR  CDS  with  5'  MfeI  site  
PBpr001-­‐006   OpIE2  promoter/HygR  CDS/OpIE2  3’  UTR  Transcriptional  Terminator,  
with  5'  MfeI  and  3'  NheI  
PBpr028-­‐012   Re-­‐amplification  of  PBpr011-­‐012  with  5'  extension  
PBpr007-­‐012   OpIE2  promoter/mAG  CDS/OpIE2  3’  UTR  Transcriptional  Terminator,  
with  5'  BamHI  and  3'  SbfI  
PBpr013-­‐031   Re-­‐amplification  of  PBpr013-­‐014  with  3'  extension  
PBpr029-­‐030   ATG-­‐  PuroR  CDS/OpIE2  3’  UTR  Transcriptional  Terminator,  with  5'  
HindIII  and  3'  NotI  
PBpr013-­‐032   ATG-­‐  PuroR  CDS/OpIE2  3’  UTR  Transcriptional  Terminator,  with  5'  
HindIII  and  3'  NotI  
PBga001-­‐002   pMTL85141  prepped  for  Gibson  assembly  with  PBga003-­‐004  
PBga003-­‐004   PBsynbackbone001  prepped  for  Gibson  assembly  with  PBga001-­‐002  
PBga005-­‐006   pMTL-­‐synbackbone  prepped  for  Gibson  assembly  with  PBga007-­‐008  
PBga007-­‐008   PBpr001-­‐006  (HygR  cassette)  prepped  for  Gibson  assembly  with  
PBga005-­‐006  
PBga009-­‐010   pMTL-­‐synbackbone-­‐HygR  prepped  for  Gibson  assembly  with  PBga011-­‐
012  
PBga011-­‐012   PBpr007-­‐012  (mAG  cassette)  prepped  for  Gibson  assembly  with  
PBga009-­‐010  
PBpr007X-­‐012X   Re-­‐amplification  of  PBpr007-­‐012  with  5'  and  3'  extensions  
PBga021-­‐022   pMTL85141  prepped  for  Gibson  assembly  with  PBtransIE1  
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Figure 17 – SOE-PCR of PBpr001-004 
Successful SOE-PCR protocol assembling 
PBpr001-0014. SOE-PCR, Splicing by 
Overlap Extension Polymerase Chain 
Reaction. 
 
Figure 18 – Attempted SOE-PCR of 
HygR Cassette (PBpr001-006) 
Lanes 2-3 show failed SOE-PCR protocol of 
PBpr001-006. Lanes 4-7 show component 
pieces. SOE-PCR, Splicing by Overlap 
Extension Polymerase Chain Reaction.  
 
This SOE-PCR was reattempted with a range of annealing temperatures, 68°C, 69°C, and 
70°C, but was unsuccessful (Figure B 2).  The resulting bands from these unsuccessful SOE-
PCR reactions were consistently too small. With the suspicion that the PBpr005-006 fragment 
might have insufficient overlap, new primers were designed to further extend the 5’ overlap 
region of this fragment from 20bp to 35bp. The newly extended fragment, PBpr025-026, was 
used in an SOE-PCR with PBpr001-004 and this reaction was successful (Figure 19). 
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Figure 19 – SOE-PCR of PBpr001-006 
Successful assembly of HygR (PBpr001-006) sub-cassette in lanes 1 and 5.  
Component pieces are shown in lanes 2-4. 
 
Fragments for construction of the mAG sub-cassette (007-008, 009-010, 011-012) and the 
Puror cassette (013-014, 015-016) were isolated via PCR from their respective sources. The 
Puror CDS (PBpr013-014) was amplified such that it excluded the initial ATG-codon. All but 
PBpr011-012 were amplified successfully (Figure 20).  PBpr011-012 was successfully 
resolved by using PBpr015-016 as a template in a subsequent amplification. To avoid the issue 
encountered with the PBpr005-006 fragment, the 5’ overlap region of PBpr011-012 was 
preemptively extended from 20bp to 37bp creating PBpr028-012. A 3-way SOE-PCR was then 
performed, using fragments PBpr007-008, PBpr009-010, and PBpr028-012, to finish 
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construction of the mAzamiGreen sub-cassette. The 2-way SOE-PCR between PBpr013-014 
and PBpr015-016 was unsuccessful however.  
 
 
Figure 20 – Components of mAG and PuroR Sub-Cassettes 
Lanes 1-3 show PCR-isolated components of the mAG sub-cassette. Lanes 7-8 show PCR-isolated 
components of PuroR sub-cassette. PCR, Polymerase Chain Reaction. 
 
The 3’ overlap region of the Puror CDS was extended from 20bp to 49bp, creating fragment 
PBpr013-031 (Figure 21).  A new SOE-PCR was attempted between 013-031 and 015-016, 
using elongation times of both 1 and 2 minutes, but these were unsuccessful (Figure B 3, 
Figure B 4).  A re-amplification of PBpr015-016 using itself as a template showed no bands, 
indicating that this fragment may have degraded (Figure 22).  This fragment was subsequently 
   83 
re-isolated from the original plasmid. In addition to this, two new sets of external primers were 
designed that exhibited improved Ta compatibility. A successful SOE-PCR was performed 
between PBpr013-031 and PBpr015-016 using external primers PBpr029 & PBpr030, and 
PBpr013 & PBpr032 (Figure 23).  The resulting PBpr029-030 codes for a transcriptionally 
deficient Puror gene. Once all three sub-cassettes were constructed, they were sequenced to 
verify their integrity.  
 
 
Figure 21 – Puro CDS Extension 
Lanes 2-3 show 3’-extended PuroR CDS. CDS, Coding Sequence. 
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Figure 22 – Diagnostic of PuroR Fragments 
Gel showing unexpected absence of PBpr015-016 
Fragment necessary for construction of the PuroR 
sub-cassette. 
 
Figure 23 – Assembly of PuroR sub-cassette 
Successful SOE-PCR protocol using 
redesigned outer primers. SOE-PCR, Splicing 
by Overlap Extension Polymerase Chain 
Reaction. 
 
6.1.2  Assembling  the  Sub-­Cassettes  
The high GC content of the fC31 attachment sites makes them difficult to manipulate 
through traditional cloning. To avoid issues in this area, a “recombinatorial backbone” was 
synthesized via Thermo GeneArt which contained the FRT regions, attP regions, attB regions, 
as well as restriction sites between them.  
The contiguous region containing the FRT sites and the attP sites was cloned into the 
plasmid pMTL85141 via Gibson Assembly. pMTL85141 is a basic E. coli cloning vector 
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exhibiting chloramphenicol resistance, and was acquired from the Aucoin Lab (University of 
Waterloo). Primers used were PBga001, PBga002 (on pMTL85141) and PBga003, PBga004 
(on the synthesized DNA PBsynbackbone001). The assembly (pMTL-synbackbone) was 
transformed into E. coli DH5a, grown overnight, and miniprepped.  
The Hygr cassette was cloned into pMTL-synbackbone via Gibson Assembly, such that it is 
placed in between the two FRT sites. Primers used were PBga005, PBga006 (on pMTL-
synbackbone) and PBga007, PBga008 (on Hygr cassette). The assembly (pMTL-synbackbone-
Hyg) was transformed into E. coli DH5a, grown overnight, and miniprepped. 
Next, preparations to clone the mAzamiGreen cassette into pMTL-synbackbone-Hyg were 
made. However, the initial PCR with Gibson primers (PBga009, 010, 011, 012) resulted in 
smeary diffuse products for PBga011-012 (Figure 24).  Bands were extracted and a Gibson 
reaction was attempted, but was unsuccessful. An unsuccessful attempt was made to form a 
Gibson assembly between PBga009-010 and the initial mAG cassette (PBpr007-012). An 
attempt was made to re-prep PBpr007-012 for Gibson assembly using PBga011 and PBga012 
at a range of temperatures (60°C, 66°C, 72°C), with the thought that lower annealing 
temperatures might allow for a successful amplication. This still resulted in some high-
molecular-weight smearing, but with a distinct band edge (Figure 25).  The band resulting 
from the 72°C reaction was extracted and used in a Gibson assembly with PBga009-010 and 
transformed into E. coli. This reaction appeared to be successful, although at a relatively low 
transformation efficiency (12 colonies grew successfully). Three colonies were backed up and 
miniprepped.  
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Figure 24 – Gibson Prep of mAG Cassette 
Amplification of the mAG sub-cassette with 
Gibson primers (PBga011-012) results in diffuse 
bands, lanes 2 & 5. Gibson prep of pMTL-
synbackbone-HygR shown in lanes 1 & 4.  
 
Figure 25 – Temperature Course of Gibson 
Prep, PBga011-012 
Gibson prep of PBga011-012 performed at 60°C, 
66°C, and 72°C. All result in diffuse bands 
with high-molecular weight smears. 
 
pMTL-synbackbone-Hyg-mAG was prepped for Gibson assembly using Gibson primers 
PBga013 and PBga014. Unexpectedly, this PCR showed no results when run on a gel. Gibson 
prep of PBpr029-030 with primers PBga015-016 also showed nothing. These PCR reactions 
were retried at new temperatures (67°C, 72°C) but still showed no bands (Figure 26).  A 
control re-amplification of PBpr029-030 was included and successful.  
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Figure 26 – Temperature Course of Gibson Prep on PBga015-016 from Two Templates 
Fragments PBpr013-032 and PBpr029-030 were both used as templates for an attempted 
Gibson prep of PBga015-016. Reactions were carried out at 67°C and 72°C. Control re-
amplifications of PBpr013-032 and PBpr029-030 are shown in Lanes 6 and 7 respectively.  
 
Gibson assemblies were then sequenced to confirm the proper construction of pMTL-
synbackbone-Hyg-mAG. However, sequencing results showed an incorrect assembly; the 
mAG cassette appeared to be absent from the plasmid.  
PBga009-010 and PBpr007-012 were both reamplified, and another Gibson assembly was 
attempted, but no colony growth was detected. Extension primers (PBga009X, PBga010X) 
were designed in an effort to increase PBga009-010’s overlap regions with PBpr007-012. 
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However, the PCR amplification using these primers showed no bands. Alternate annealing 
temperatures were explored (60°C, 66°C, 72°C) but still showed no bands. It was then decided 
to attempt extending the PBpr007-012 fragment instead. Extension primers PBpr007X and 
PBpr012X were used in a PCR on PBpr007-012 at 64°C, 66°C, and 68°C. All showed proper 
sized bands, but with some full-lane smearing. The 64°C sample appeared to be the clearest, 
and was extracted for later use. However, it was noted in the nanodrop that the 260/230 ratio 
was demonstrably low, at 0.04. A Gibson assembly was attempted between PBga009-010 and 
PBpr007X-012X, but was unsuccessful.  
It was decided to eschew Gibson assembly in favour of restriction cloning. Double digests 
of pMTL-synbackbone-Hyg and PBpr007-012 were performed using BamHI and SdaI, and 
the fragments were then ligated and transformed into E. coli. However, no colony growth was 
seen. Instead of re-attempting with PBpr007-012, a restriction cloning protocol was used on 
the Puror cassette. pMTL-synbackbone-Hyg and PBpr029-030 were digested with HindIII and 
NotI enzymes, ligated, and transformed into E. coli. Minipreps of three different colonies were 
prepared, but nanodrop readings again showed very low 260/230 readings (0.31-0.62) and low 
DNA concentration (2.24-17.12 ng/µl). 
 
6.1.3  PiggyBac  Transposase  
Plasmids pBSII-IE1-orf, containing the piggyBac transposase CDS, and pXLBacII, 
containing the piggyBac terminal repeat domains were obtained from Dr. Donald Jarvis 
(University of Wyoming). Although these plasmids were listed as containing Ampr regions, 
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but no colonies resulted when plated on ampicillin. Transformants were plated on kanamycin, 
tetracycline, and chloramphenicol plates. pXLBacII-transformants produced colony growth on 
kanamycin, and these colonies were miniprepped to recover the plasmid. However, pBSII-IE1-
orf did not produce colonies on any of these plates.  
To confirm that the plasmid labelled pXLBacII did indeed contain piggyBac TRDs, it was 
sequenced using TRD-binding primers. Sequencing results confirmed that this plasmid did 
contain the piggyBac TRD regions.  
To determine whether the sample labelled pBSII-IE1-orf was the proper plasmid, a 
restriction map using BamHI was produced. This should have produced fragments of 2010bp 
and 3513bp, but this was not reflected in the gel (Figure 27).  Additionally, a PCR was 
performed using primers designed to amplify a 755bp inner portion of the piggyBac CDS 
(PBpr023, PBpr024) which resulted in no amplified fragment. These two procedures 
confirmed that the piggyBac Transposase CDS was not present in the samples received.  
To remedy the lack of a piggyBac CDS, a new DNA fragment, PBtransIE1, was synthesized 
as a gBlock via IDT Inc (Integrated DNA Technologies Inc., Skokie IL). This fragment 
contained an Sf9-optimized piggyBac Transposase CDS with an upstream IE1 promoter. This 
synthesized fragment required the addition of a 3’ UTR, and needed to be placed in a plasmid 
backbone. 
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Figure 27 – Restriction Map of Sample Labelled pBSII-IE1-orf 
Digestion of sample with BamHI resulted in a banding pattern not consistence with the 
expected restriction map of pBSII-IE1-orf.  
 
Primers PBpr033 and PBpr034 were used in a PCR amplification of PBtransIE1 to prepare 
it for an SOE-PCR reaction. However, the resulting gel showed smearing, as well as a double 
band pattern (Figure 28).  A second attempt at this reaction, using redesigned primers PBpr037 
and PBpr038, showed reduced smearing but still presented a double-banding pattern (Figure 
29). 
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Figure 28 – Amplification of PBtransIE1 
(PBpr033-034) 
Amplification of PBtransIE1 with primers 
PBpr033 and PBpr034 results in double-band 
pattern. 
 
Figure 29 – Amplification of PBtransIE1 
(PBpr037-038) 
Amplification of PBtransIE1 with redesigned 
primers PBpr037 and PBor038 still results in 
double-band pattern. 
 
It was subsequently decided to move PBtransIE1 into a plasmid first, and append the 3’ UTR 
afterwards. Gibson primers PBga021 and PBga022 were used to amplify the pMTL backbone, 
but this produced no amplified fragment. These primers were subsequently used on pMTL-
synbackbone with a similar negative result. A second attempt at a PCR amplification of pMTL 
using PBga021 and PBga022, but with the annealing temperature raised from 59°C to 72°C, 
resulted in a properly sized band (Figure 30). 
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Figure 30 – Gibson Prep of pMTL as PBga021-022, 72°C 
Amplifying plasmid pMTL with Gibson primers PBga021 and PBga022 results in defined band after raising 
temperature from 59°C (not shown) to 72°C (shown) 
 
A Gibson assembly was attempted between PBga021-022 and PBtransIE1, but no colony 
growth was detected. An amplification of PBtransIE1 with primers PBga023 and PBga24 
resulted in a similar double band pattern as seen before.  
A series of forward primers were designed (PBpr040, PBpr042, PBpr043) that bind to 
intermittent regions along PBtransIE1. These were paired with reverse primer PBpr041, and 
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amplified via PCR. The result was a series a series of double bands, shifted in size. The space 
between the bands, however, remained consistent (Figure 31). 
 
 
Figure 31 – Forward Primer Series on PBtransIE1 
A series of PCR amplications on PBtransIE1 using various forward primers (PBpr040, 
PBpr042, PBpr043), always with reverse primer PBpr041, shows double-band pattern that 
shits in size relative to the binding position of the forward primer. PCR, Polymerase Chain 
Reaction. 
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6.2  Discussion  
The cassette construction process was heavily marred with unexpected complications. 
Thus, a great deal of the methodology and results was dedicated to attempts at troubleshooting 
these complications. While ultimately unsuccessful in completing the final product, a number 
of useful pieces of information were collected through this process. 
SOE-PCR protocols often suggest that overlap regions of between 20-30bp are sufficient for 
a successful reaction (Warrens, Jones, & Lechler, 1997).  While this was sufficient for several 
SOE-PCR reactions, ones that became troublesome were invariably remedied by extending the 
overlap regions to >=35bp. When appending a 3’ UTR onto the Hygror CDS a 35bp overlap 
was used, while the same reaction in the Puror cassette required a 49bp overlap. In retrospect, 
failed SOE-PCRs often surfaced when instituting a 3’ UTR. Extending the overlap regions 
here appeared to successfully counteract the low binding affinity of these sequences.  
The Gibson Assembly phase of cassette construction was initially successful, with the 
recombinatorial backbone slotting into pMTL and the Hygror cassette being cleanly assembled 
afterwards. However, things became problematic when attempting to assemble the mAG 
cassette (PBpr007-012). The presence of high molecular weight smears, such as those seen in 
Figure 24 and Figure 25, are often caused by plasmid template contamination. However, in 
these instances the template (PBpr007-012) was 24bp shorter than the predicted product, so 
template contamination could be safely ruled out.  
There was some clear evidence of primer dimers forming in reactions run on these gels, so 
some element of mispriming was a possibility. The temperature series shown in Figure 25 did 
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show some qualitative improvement with respect to primer dimers and smearing. This would 
indicate that increasing the stringency of the PCR reaction was positively improving the result. 
Unfortunately, a Ta higher than 72°C was untenable.  
A similar type of smearing was found when attempting to amplify the Puror cassette 
(PBpr029-030) with PBga015 and PBga016 (Figure 26).  After the fact, it was noted that the 
reverse primers in the PBga011-012 and PBga015-016 PCR preps exhibited very high DG 
score for homodimers, -12.64kcal and -9.26kcal respectively (calculated via Benchling). It is 
a reasonable hypothesis that 3’ dimerization was contributing heavily to the unsuccessful 
results shown in Figure 25 and Figure 26.  
The highly AT rich 3’ regions in conjunction with the presence of palindromic restriction 
sites made designing useful primers very difficult for these cassettes, as these characteristics 
lend themselves to dimerization problems. However, the restriction sites offered an alternative 
approach to assembly. A pseudo-successful attempt at integrating the Puror cassette into 
pMTL-synbackbone-Hygro was made via a double digest/ligation. However, upon 
nanodropping the miniprepped plasmids, the 260/230 readings were prohibitively low.  
Low 260/230 readings typically indicate a contaminant of some kind, such as carbohydrates, 
phenols, or glycogen, has entered the sample. In instances where a commercial miniprep 
column is used, and in particular an older kit such as the one used here, residual guanidine 
contamination was likely the issue (Scientific, 2007). 
The lack of a piggyBac transposase CDS, which was originally to be sourced from the 
plasmid pBSII-ie1-orf, instigated a series of problems. The alternative to sourcing this CDS 
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from a plasmid was to have the sequence synthesized. An advantage of this method was it 
allowed for the piggyBac CDS to be codon optimized for expression in Sf9 cells. The sequence 
designed for synthesis, PBtransIE1, included an upstream IE1 promoter. However, as a cost-
cutting measure, the 3’ UTR necessary for proper gene transcription was omitted – a decision 
that had unexpected ramifications.  
Amplification of PBtransIE1, be it preparation for SOE-PCR (using PBpr033/PBpr034 and 
PBpr037/PBpr038) or Gibson Assembly (PBga023/PBpr024), invariably resulted in a double-
band pattern (Figure 28 and Figure 29).  Initially, it was attempted to perform a Gibson 
Assembly without doing a PCR preparation on PBtransIE1, which would have avoided the 
need to resolve the double banding issue. However this was unsuccessful.  
The brightest band in the double band was showing up at ~1600bp, whereas the predicted 
product should be ~2300bp. It is likely that one or both of the primers was mispriming relative 
to the template, resulting in a shorter amplicon. To gain insight into this, a series of forward 
primers (PBpr040, PBpr042, PBpr043) was used to amplify PBtransIE1, such that each 
reaction had a differently sized amplicon (Figure 31).  The double banding pattern remained 
present, but each lane was shifted in size. The size shift indicates that the forward primers were 
binding properly. Therefore, the double band pattern must have been the result of mispriming 
by the reverse primer. 
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Chapter  7  
Limiting  Dilution  of  Sf9  Cell  Line  
During the construction of the recombinant cassettes, and the trouble-shooting therein, a 
series of Limiting Dilution test runs were enacted. This would help determine optimal 
parameters for clonal isolation of the recombinant Sf9 cell line. Parameters of interest were: 
fresh vs. conditioned media, supplementation with Fetal Bovine Serum (FBS), and plate 
material.  
Limiting dilution functions by diluting a healthy culture of cells, and aliquoting them such 
that only 1 new cell is present in each new culture vessel. In this instance, a culture vessel 
consisted of 1 well in a 96-well plate. Cells are then grown to confluency and a new 
maintenance culture is established.  
Two types of VWR tissue-culture-treated 96 well plates were examined: flat-bottom and U-
bottom. Media treatments consisted of 100% conditioned Sf900III media, and a 50/50 mixture 
of conditioned and fresh Sf900III media. Trials of FBS supplementation were performed at 
levels of 0%, 2%, and 10% FBS by volume. 
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7.1  Materials  and  Methods  
7.1.1  Preparing  Conditioned  Media  
Allow an Sf9 suspension culture to grow to ~3x106 cell/ml in SF900III nutrient media. 
Transfer culture into 50ml conical Falcon centrifuge tubes. Pellet cultures at 150xG for 5 
minutes. In a biosafety hood, vacuum filter the media through a 0.2µm pore filter. Securely 
cap conditioned media and store at 4°C. 
 
7.1.2  Limiting  Dilution  
In a biosafety hood, using sterile serological pipettes, initial media treatments were 
prepared in 20ml volumes. A cell dilution was prepared beginning with a suspension culture 
of Sf9 cells at ~5x105 cells/ml. Using 27°C fresh Sf900III media, serial 1/10 dilutions were 
performed to produce a suspension of 5x102 cells/ml. 100µl of the Sf9 cell dilution was 
transferred into each media preparation to produce a cell density of 2.5 cells/ml. Tubes were 
gently inverted to mix cells into media. Cell/media preparations were aliquoted into 96-well 
tissue-culture treated plates, at a volume of 200µl/well. Plates were covered and incubated in 
an airtight container with a clean-bath treated sponge at 27°C. 
Wells were inspected within 12 hours of plating to indicate wells containing single cells. 
Inspections were carried out using a Zeiss Axiovert 40 C phase contrast microscope. Cells 
were inspected weekly to monitor growth, and replace media.  
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7.2  Results  
Trial 1 for performing limiting dilution on an Sf9 culture examined two different media 
preparations, as well as two different tissue-culture treated plate types (Table 8). While the 
flat-bottom plates were fully transparent, the round-bottom plates exhibited a slight 
translucence. While it was initially suspected that cells would still be discernable through them, 
this was incorrect. Therefore, all entries for the round bottom plates are listed as Not 
Determinable (ND) (Table 9). 
Table 8 - Trial 1, Limiting Dilution Treatments 
Plate   Conditioned  Media  (%)   Fresh  Media  (%)   Plate  Type  
1   100   0   Flat-­‐Bottom  
2   100   0   Round-­‐Bottom  
3   50   50   Flat-­‐Bottom  
4   50   50   Round-­‐Bottom  
 
Table 9 – Trial 1, Limiting Dilution Cell Counts 
Week-over-week data is presented as a percentage of wells containing isolated, viable cells.  
ND, Not Determinable 
Plate   1   2   3   4  
Total  Cells  Plated   44   ND   43   ND  
Wells  Containing  Isolated,  Viable  
Cells   25   ND   15   ND  
Week  1  –  Viable  Cells  Remaining  
(%)   0   ND   33.33   ND  
Week  1  –  Cells  Showing  Division  (%)   0   ND   13.33   ND  
Week  2  –  Viable  Cells  Remaining  
(%)   0   ND   0   ND  
Week  2  –  Cells  Showing  Division  (%)   0   ND   0   ND  
 
   100 
Trial 2 for performing a limiting dilution was performed entirely on flat-bottom polystyrene 
tissue-culture-treated 96-well plates. Six different media formulations were used in this trial 
(Table 10). At two weeks, plate C was found to be contaminated by a fungus, and was 
subsequently discarded. All entries for past this point on the plate were labelled as C 
(contaminated) (Table 11).  
 
Table 10 - Trial 2, Limiting Diluiton Treatments 
FBS, Fetal Bovine Serum 
Plate   Conditioned  Media  (%)   Fresh  Media  (%)   FBS  (%)  
A   100   0   0  
B   98   0   2  
C   90   0   10  
D   50   50   0  
E   49   49   2  
F   45   45   10  
 
     For both trials, week-over-week data was only collected for wells containing isolated cells. 
Information was compartmentalized based on whether a well contained cells that appeared 
alive (viability), and whether there appeared to be new cells present during inspection relative 
to the previous inspection (division). During this inspection process, viability was assessed 
visually via phase-contrast microscopy; cells that appeared qualitatively healthy were deemed 
to be viable. 
 
 
   101 
Table 11 – Trial 2, Limiting Dilution Cell Counts 
Week-over-week data is presented as a percentage of wells containing isolated, viable cells.  
C, Contaminated 
Plate   A   B   C   D   E   F  
Total  Cells  Plated   49   34   47   56   41   32  
Wells  Containing  Isolated,  Viable  
Cells   19   15   21   33   18   20  
Week  1  –  Viable  Cells  Remaining  (%)   21.05   46.66   42.85   36.36   72.22   90  
Week  1  –  Cells  Showing  Division  (%)   0   0   4.76   6.06   11.11   20  
Week  2  –  Viable  Cells  Remaining  (%)   0   20   C   6.06   11.11   25  
Week  2  –  Cells  Showing  Division  (%)   0   0   C   0   0   5  
Week  3  –  Viable  Cells  Remaining  (%)   0   0   C   0   5.55   5  
Week  3  –  Cells  Showing  Division  (%)   0   0   C   0   0   0  
Week  4  –  Viable  Cells  Remaining  (%)   0   0   C   0   0   0  
Week  4  –  Cells  Showing  Division  (%)   0   0   C   0   0   0  
 
 
7.3  Discussion  
Limiting Dilution, while time consuming, is generally considered to be the optimal method 
for cell-line development when producing a clonal-isolate is a priority. By mechanically 
isolating individual cells, great confidence can be had as to the monoclonal nature of the 
resultant population. However, such an extreme dilution can cause a great deal of stress on a 
cell. It has been noted that not all established insect cell lines are compatible with the limiting 
dilution procedure, and that even in successful trials upwards of 50% of isolates will die 
(Harrison & Jarvis, 2010).  Nevertheless, several lepidopteran lines, including the Sf9 and 
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High-Five lines, have successfully undergone this procedure in the past (Fernandes et al., 2012; 
Steele et al., 2017). 
In the literature, there are some variations in the approach to limiting dilution. One example 
using Sf9 cells utilized fully conditioned media supplemented with 10% FBS (Fernandes et 
al., 2012).  A trial with the High-Five cell line was successfully implemented using a 50/50 
split of fresh and conditioned media, with no FBS supplementation (Steele et al., 2017).  
Additionally, there are some variations on the exact definition of conditioned media; the 
former listed the media as the supernatant of exponentially growing cells, while the latter listed 
CM as media from 48-hour growth cultures (Fernandes et al., 2012; Steele et al., 2017).  Other 
groups have harvested CM from cultures between 2-5x106 cells/ml, or from 3 day growth 
cultures (Calles et al., 2006; Doverskog et al., 2000).  
Unfortunately, no healthy cell lines were successfully produced in these trials. The reasons 
for this are unclear. However, by examining the number of cells that survived to the 1 week 
mark in the second trial, a number of suggestions can be made for further work. Detailed 
statistics for these comparisons can be found in Appendix C. 
In the treatment set with a 50/50 media split (plates D-F), the addition of FBS provided a 
statistically significant boost in cell health. Viability improved from 36.4% in plate D to 72.2% 
in plate E and 90% in plate F (p values of 6.6x10-3 and 5.0x10-6 respectively) (Table C 3,  
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Table C 4). The evidence for improved cell viability due to FBS is weaker in the plates with 
fully conditioned media. Viability improved from 21.1% in plate A to 46.7% in plate B and 
42.9% in plate C (p values of 6.5x10-2 and 7.3x10-2 respectively) (Table C 1, Table C 2). 
 Interestingly, increasing the amount of FBS from 2% to 10% did not have a pronounced 
effect on cell viability. The difference between plate B & C, and E & F, were not statistically 
significant. Further data would be useful to be certain that this conclusion holds. Assuming it 
does, however, this would suggest that limiting dilutions should be carried out using 2% FBS 
rather than 10%. The added difficulty of weaning a cell-line off of 10% FBS once established 
does not appear to be accompanied by any advantage during the development process. 
  A comparison between plate D and A shows an increase in viability from 21.1% to 36.4% 
(Table C 7). However, this comparison falls well short of p=0.05. When data from plates 1 
and 3 from trial 1 are included, a statistically significant increase of 9.1% to 35.4% was seen 
when going from fully conditioned media to split media (p=0.001) ( 
Table C 10). Additionally, comparing plate F and C wherein media conditions change but 
FBS remains constant showed an increase from 42.9% to 90% in favour of split media 
(p=0.0005) (Table C 9). These results would suggest that a 50/50 split of conditioned and fresh 
media is advantageous for Sf9 viability in limiting dilution conditions. 
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Chapter  8  
Conclusions  &  Recommendations  
While the final goal of a fC31-competent Sf9 cell line was not realized, a number of useful 
takeaways can be made from this project. Firstly, the design choice of utilizing mAzamiGreen 
and mKOk as a paired fluorescent reporter system appears to be a successful one. Each of the 
three possible expression permutations (singular mAG, singular mKOk, and co-expressed 
mAG+mKOk) were clearly differentiable. No treatment saw more than 0.7% of expressing 
cells register in a competing treatment’s gate. This result also demonstrates that mKOk exhibits 
strong enough flouresence to be used with mAG in any future co-expression studies.  
Limiting dilution of an Sf9 cell culture remains a difficult procedure. Results from this 
project may provide suggestions on how to maximize the chance of successfully creating a 
clonal isolate. There is some evidence to suggest that an application of mixed fresh/conditioned 
media better promotes cell viability when compared to a treatment of purely conditioned 
media. This experiment only tested two permutations - 100% conditioned and 50/50 
fresh/conditioned – and so exploration of other ratios may prove to be fruitful in the future. 
Additionally, trials examining to what effect the degree of media conditioning has on Sf9 cells 
in the context of limiting dilution would be useful. Some investigation has been performed in 
the context of standard growth conditions, but not in single-cell growth conditions (Doverskog 
et al., 2000). 
Unsurprisingly, evidence showed that the addition of FBS improved Sf9 viability week-
over-week during a limiting dilution protocol. What is interesting, however, is that a 10% FBS 
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treatment was not significantly better at improving cell viability week-over-week than a 2% 
FBS treatment. When taken with the fact that any successfully isolated cell line will need to be 
subsequently weaned off of FBS, a low-concentration FBS supplement appears to be advisable. 
However, given that the end goal of the limiting dilution protocol was unsuccessful, further 
work is required on this front. 
Ultimately, construction of the fC31-competent gene cassette was unsuccessful. In 
retrospect, the construction failures often revolved around manipulating the AT-rich 3’ UTR 
fragments. The extremely low GC-content of these regions made them difficult to handle in 
isolation, and the construction plan did not adequately account for this. This was exacerbated 
by including restriction sites, which are inherently palindromic, at the 3’ ends of these regions. 
In the end, the design decision to include “backwards compatibility” for restriction cloning 
protocols proved to be a poor one.  
Given that restriction cloning is an aging technology and restriction sites may interfere with 
constructing genes via Gibson assembly by promoting 3’ fragment dimerization, it is 
recommended to eschew, or minimize, the inclusion of restriction sites in future synthetic 
biology endeavours. Furthermore, it is recommended that handling AT-rich transcriptional 
terminator regions in isolation should be avoided whenever possible. Their low Tm and 
predilection towards mispriming make them difficult assemble. It is also recommended that 
further work be done to optimize and standardize a media formulation for Sf9 limiting dilution 
protocols. This includes exploration of Conditioned Media/Fresh Media ratios, as well as the 
degree of media conditioning.  
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At the time the experimental section of this project was concluded, the genetic components 
of the proposed fC31-competent Sf9 cell line remain in a state of semi-completion. Based on 
the design considerations and the limited results attained, the end goal of a functional cell line 
still appears to be achievable. In conclusion, it is recommended that pursuing the completion 
of this work is still a worthwhile endeavour. 
  
 Appendix  A  
Oligonucleotide  Primers  
Oligonucleotide primers are used in PCR amplification protocols. Labels include the code 
“pr” if the intended use was for PCR or SOE-PCR reactions. Labels including the code “ga” 
were intended for use in preparing a Gibson Assembly. 
Table 12 - Oligonucleotide Primers 
Dir. – Direction: Forward, Reverse 
Name   Dir.   Sequence  
PBpr001   F   atcgacaattgggtacccatgatgataaacaatgtatggtgctaatgttgc  
PBpr002   R   agacgtcgcggtcagctcaggctttcccataacagatgctgttcaactgtgtttacc  
PBpr003   F   atgggaaagcctgagctgacc  
PBpr004   R   ctaagataatgacagttcctttgccctcggacgag  
PBpr005   F   aggaactgtcattatcttagtttgtattgtcatgttttaatacaatatg  
PBpr006   R   atcgcgctagccgtcagcaacgaccctgc  
PBpr007   F   atcgcggatcccatgatgataaacaatgtatggtgctaatgttgc  
PBpr008   R   cttcatctcgggcttgatcacgctcaccataacagatgctgttcaactgtgtttacc  
PBpr009   F   atggtgagcgtgatcaagcccgag  
PBpr010   R   ctaagataatgacagttacttggcctggctgggcagc  
PBpr011   F   agtaactgtcattatcttagtttgtattgtcatgttttaatacaatatg  
PBpr012   R   actatcctgcaggcgtcagcaacgaccctgc  
PBpr013   F   atcgtaagcttaccgagtacaagcccacgg  
PBpr014   R   ctaagataatgacagtcaggcaccgggcttgc  
PBpr015   F   cctgactgtcattatcttagtttgtattgtcatgttttaatacaatatg  
PBpr016   R   attgcgcggccgccgtcagcaacgaccctgc  
PBpr017   F   cgttggaagacacagcatgacc  
PBpr018   R   ttccgagggctccgataaatgg  
PBpr019   F   tagccatttatcggagccctcg  
PBpr020   R   ttcgttagccagtccacagagg  
PBpr021   F   gccatttatcggagccctcgacttaccgcattgacaagca  
PBpr022   R   tcatgctgtgtcttccaacgccgggctgcaggaattcgat  
PBpr023   F   caaaatgtgccacacttgcagc  
PBpr024   R   ttcagtgcagagactcggctac  
PBpr025   F   ctcgtccgagggcaaaggaactgtcattatcttagtttgtattgtcatg  
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PBpr026   R   atcgcgctagccgtcagc  
PBpr027   F   atcgacaattgggtacccatgatgataaac  
PBpr028   F   gctgcccagccaggccaagtaactgtcattatcttag  
PBpr029   F   atcgtaagcttaccgagtacaagcccacggtgc  
PBpr030   R   attgcgcggccgccgtcag  
PBpr031   R   catattgtattaaaacatgacaatacaaactaagataatgacagtcaggcaccgggc  
PBpr032   R   attgcgcggccgccg  
PBpr033   F   cgatgtctttgtgatgcg  
PBpr034   R   caatacaaactaagataatgacagttagaagcaggactgg  
PBpr035   F   ccagtcctgcttctaactgtcattatcttagtttgtattgtcatgttttaatacaatatg  
PBpr036   R   cgtcagcaacgaccctgc  
PBpr037   F   cgatgtctttgtgatgcgcc  
PBpr038   R   ttagaagcaggactggcacatg  
PBpr039   F   cgcgagcacaacatcgacatgtgccagtcctgcttctaactgtcattatc  
PBpr040   F   atgggctgctccctggac  
PBpr041   R   ttagaagcaggactggcacatgtc  
PBpr042   F   ccgactgttttcgtatccgctc  
PBpr043   F   caaaatgtgccacacttgcagc  
PBpr044   R   tgtcgatgttgtgctcg  
PBpr045   R   cagatcactttcttgcac  
PBpr007X   F   ggatcccatgatgataaacaatg  
PBpr012X   R   cctgcaggcgtcagcaa  
PBga001   F   tatcggagccctcggaagaggcaaatgaaatagattgac  
PBga002   R   ctggccgtcgttttacatcttccgcttcctcgct  
PBga003   F   agcgaggaagcggaagatgtaaaacgacggccag  
PBga004   R   tctatttcatttgcctcttccgagggctccgata  
PBga005   F   cgttgctgacggctagcgggtggatggtttaagaa  
PBga006   R   tcatgggtacccaattgagacagcgtatctcacg  
PBga007   F   cgtgagatacgctgtctcaattgggtacccatgatga  
PBga008   R   tcttaaaccatccacccgctagccgtcagcaacg  
PBga009   F   ttgctgacgcctgcaggaacctgttaagcgcacc  
PBga010   R   ttatcatcatgggatcctggttcctctatatcccc  
PBga011   F   gggatatagaggaaccaggatcccatgatgataaacaatg  
PBga012   R   ggtgcgcttaacaggttcctgcaggcgtcagcaa  
PBga013   F   ttgctgacggcggccgctatgtgaagcacagcatagcc  
PBga014   R   ttgtactcggtaagcttcgcccccaactgagaga  
PBga015   F   tctctcagttgggggcgaagcttaccgagtacaagcccacgg  
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PBga016   R   atgctgtgcttcacatagcggccgccgtcagcaa  
PBga017   F   tatcggagccctcggaaacttaccgcattgacaagc  
PBga018   R   ctggccgtcgttttacacccgggctgcaggaatt  
PBga019   F   aattcctgcagcccgggtgtaaaacgacggccag  
PBga020   R   ttgtcaatgcggtaagtttccgagggctccgata  
PBga021   F   tgtgccagtcctgcttctaagaggcaaatgaaatagattgac  
PBga022   R   gtcggcgcatcacaaagacatcgtcttccgcttcctcgct  
PBga023   F   agcgaggaagcggaagacgatgtctttgtgatgc  
PBga024   R   tctatttcatttgcctcttagaagcaggactggc  
PBga025   F   cagggtcgttgctgacggaggcaaatgaaatagattg  
PBga026   R   acaatacaaactaagatttagaagcaggactggc  
PBga027   F   gccagtcctgcttctaaatcttagtttgtattgtcatgtttt  
PBga028   R   tctatttcatttgcctccgtcagcaacgaccctg  
PBga007X   F   ggatcccatgatgataaacaatg  
PBga009X   F   acccgaaaagcagggtcgttgctgacgcctgcagg  
PBga010X   R   cattagcaccatacattgtttatcatcatgggatcctggttc  
PBga012X   R   cctgcaggcgtcagcaa  
PBga021X   F   gcgagcacaacatcgacatgtgccagtcctgcttctaag  
PBga022X   R   caataacctacaaaaatgtcggcgcatcacaaagac  
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Appendix  B  
Electrophoresis  Gels  
 
Figure B 1 – Unsuccessful SOE-PCR of PBpr-001-006 
 
Figure B 2 – Temperature Series of SOE-PCR, PBpr001-006 
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Figure B 3 – Unsuccessful SOE-PCR, PBpr013-016, 1min TE 
 
Figure B 4 – Unsuccessful SOE-PCR, PBpr013-016, 2min TE 
  
   112 
Appendix  C  
Statistical  Comparisons  of  Limiting  Dilution  Treatments  
All tests of statistical significance referenced in Chapter 7 are T-tests comparing mean 
values, while assuming unequal variances. Values were calculated in Microsoft Excel. All P-
values referenced in Chapter 7 are one-tailed (pertinent cells are highlighted).  
 
Table C 1 - Means Comparison of 100% CM (A) vs. 98% CM, 2% FBS (B) 
Means comparison of cell viability in isolated wells after 1 week, between plates A & B in Trial 2, Chapter 
7. 
     B   A  
Mean   0.4667   0.2105  
Variance   0.2667   0.1754  
Observations   15   19  
Hypothesized  Mean  Dif.   0     
df   27     
t  Stat   1.5585     
P(T<=t)  one-­‐tail   0.0654     
t  Critical  one-­‐tail   1.7033     
P(T<=t)  two-­‐tail   0.1308     
t  Critical  two-­‐tail   2.0518       
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Table C 2 - Means Comparison of 100% CM (A) vs. 90% CM, 10% FBS (C) 
Means comparison of cell viability in isolated wells after 1 week, between plates A & C in Trial 2, Chapter 
7. 
     C   A  
Mean   0.4286   0.2105  
Variance   0.2571   0.1754  
Observations   21   19  
Hypothesized  Mean  Dif.   0     
df   38     
t  Stat   1.4878     
P(T<=t)  one-­‐tail   0.0725     
t  Critical  one-­‐tail   1.6860     
P(T<=t)  two-­‐tail   0.1451     
t  Critical  two-­‐tail   2.0244       
 
Table C 3 - Means Comparison of 50% CM, 50% FM (D) vs. 49% CM, 49% FM, 2% FBS (E) 
Means comparison of cell viability in isolated wells after 1 week, between plates D & E in Trial 2, Chapter 
7. 
     E   D  
Mean   0.7222   0.3636  
Variance   0.2124   0.2386  
Observations   18   33  
Hypothesized  Mean  Dif.   0     
df   37     
t  Stat   2.5992     
P(T<=t)  one-­‐tail   0.0067     
t  Critical  one-­‐tail   1.6871     
P(T<=t)  two-­‐tail   0.0133     
t  Critical  two-­‐tail   2.0262       
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Table C 4 - Means Comparison of 50% CM, 50% FM (D) vs. 45% CM, 45% FM, 10% FBS (F) 
Means comparison of cell viability in isolated wells after 1 week, between plates D & F in Trial 2, Chapter 
7. 
     F   D  
Mean   0.9000   0.3636  
Variance   0.0947   0.2386  
Observations   20   33  
Hypothesized  Mean  Dif.   0     
df   51     
t  Stat   4.9028     
P(T<=t)  one-­‐tail   0.000005     
t  Critical  one-­‐tail   1.6753     
P(T<=t)  two-­‐tail   0.0000     
t  Critical  two-­‐tail   2.0076       
 
Table C 5 - Means Comparison of 98% CM, 2% FBS (B) vs. 90% CM, 10% FBS (C) 
Means comparison of cell viability in isolated wells after 1 week, between plates B & C in Trial 2, Chapter 
7. 
     C   B  
Mean   0.4286   0.4667  
Variance   0.2571   0.2667  
Observations   21   15  
Hypothesized  Mean  Dif.   0     
df   30     
t  Stat   -­‐0.2199     
P(T<=t)  one-­‐tail   0.4137     
t  Critical  one-­‐tail   1.6973     
P(T<=t)  two-­‐tail   0.8275     
t  Critical  two-­‐tail   2.0423       
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Table C 6 - Means Comparison of 49% CM, 49% FM, 2% FBS (E) vs. 45% CM, 45% FM, 
10% FBS (F) 
Means comparison of cell viability in isolated wells after 1 week, between plates E & F in Trial 2. 
     F   E  
Mean   0.9000   0.7222  
Variance   0.0947   0.2124  
Observations   20   18  
Hypothesized  Mean  Dif.   0     
df   29     
t  Stat   1.3824     
P(T<=t)  one-­‐tail   0.0887     
t  Critical  one-­‐tail   1.6991     
P(T<=t)  two-­‐tail   0.1774     
t  Critical  two-­‐tail   2.0452       
 
Table C 7 - Means Comparison of 100% CM (A) vs. 50% CM, 50% FM (D) 
Means comparison of cell viability in isolated wells after 1 week, between plates A & D in Trial 2, 
Chapter 7. 
     D   A  
Mean   0.3636   0.2105  
Variance   0.2386   0.1754  
Observations   33   19  
Hypothesized  Mean  Dif.   0     
df   43     
t  Stat   1.1932     
P(T<=t)  one-­‐tail   0.1197     
t  Critical  one-­‐tail   1.6811     
P(T<=t)  two-­‐tail   0.2393     
t  Critical  two-­‐tail   2.0167       
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Table C 8 - Means Comparison of 98% CM, 2% FBS (B) vs. 49% CM, 49% FM, 2% FBS (E) 
Means comparison of cell viability in isolated wells after 1 week, between plates B & E in Trial 2, Chapter 
7. 
     E   B  
Mean   0.7222   0.4667  
Variance   0.2124   0.2667  
Observations   18   15  
Hypothesized  Mean  Dif.   0     
df   28     
t  Stat   1.4859     
P(T<=t)  one-­‐tail   0.0742     
t  Critical  one-­‐tail   1.7011     
P(T<=t)  two-­‐tail   0.1485     
t  Critical  two-­‐tail   2.0484       
 
Table C 9 - Means Comparison of 90% CM, 10% FBS (C) vs. 45% CM, 45% FM, 10% FBS (F) 
Means comparison of cell viability in isolated wells after 1 week, between plates C & F in Trial 2, Chapter 
7. 
     F   C  
Mean   0.9000   0.4286  
Variance   0.0947   0.2571  
Observations   20   21  
Hypothesized  Mean  Dif.   0     
df   33     
t  Stat   3.6176     
P(T<=t)  one-­‐tail   0.0005     
t  Critical  one-­‐tail   1.6924     
P(T<=t)  two-­‐tail   0.0010     
t  Critical  two-­‐tail   2.0345       
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Table C 10 - Means Comparison of 100% CM (A+1) vs. 50% CM, 50% FM (D+3) 
Means comparison of cell viability in isolated wells after 1 week. Comparison is between the aggregate 
data of plate A in Trial 2 & plate 1 in Trial 1 vs plate D in Trial 2 & plate 3 in Trial 1, Chapter 7. 
     D+3   A+1  
Mean   0.3542   0.0909  
Variance   0.2336   0.0846  
Observations   48   44  
Hypothesized  Mean  Dif.   0     
df   78     
t  Stat   3.1951     
P(T<=t)  one-­‐tail   0.0010     
t  Critical  one-­‐tail   1.6646     
P(T<=t)  two-­‐tail   0.0020     
t  Critical  two-­‐tail   1.9908       
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Appendix  D  
Example  Reactions  
Example reactions for protocols listed in Chapter 4 are listed here. 
Table D 1 - Example PCR Set-Up 
Component   Value  
5x  HF  Buffer   10  µl  
10mM  dNTPs   1  µl  
Phusion  Polymerase   0.5  µl  
Primer  1   1.25  µl  
Primer  2   1.25  µl  
Template  (1/20)   2  µl  
dH2O   34  µl  
Length   1500  bp  
Elongation  Time   1.5  min  
Ta   65°C  
 
Table D 2 - Example SOE-PCR Set-Up 
Component   Mix  A   Mix  B  
5x  HF  Buffer   5  µl   5  µl  
10mM  dNTPs   0.5  µl   0.5  µl  
Phusion  Polymerase   0.25  µl   0.25  µl  
Fragment  1   1  µl   0  µl  
Fragment  2   2  µl   0  µl  
Primer  1   0  µl   1.25  µl  
Primer  2   0  µl   1.25  µl  
dH2O   16.25  µl   16.25  µl  
Combined  Length   1600bp   1600bp  
Elongation  Time   90  sec   90  sec  
Ta   67°C   63°C  
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Table D 3 - Example Gibson Assembly Set-Up 
Component   Volume  
2x  Gibson  Assembly  Master  Mix   5  µl  
Insert  Fragment   2  µl  
Backbone  Fragment   0.5  µl  
dH2O   2.5  µl  
 
Table D 4 - Example Restriction Digest Set-Up 
Component   Volume  
DNA   2  µl  
FastDigest  Green  Buffer   2  µl  
SdaI   1  µl  
BamHI   2  µl  
dH2O   14  µl  
 
Table D 5 - Example Ligation Set-Up 
Component   Volume  
10x  T4  Buffer   2  µl  
T4  Ligase   0.2  µl  
Insert  DNA   6  µl  
Backbone  DNA   2  µl  
dH2O   9.8  µl  
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Table D 6 - Example Agarose Gel Set-Up 
Component   Volume  
TAE  Buffer   50  ml  
Agarose  Powder   0.8%-­‐1.4%  w/v  
20,000x  RedSafe  Dye   2.5  µl  
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Appendix  E  
Pseudo-­attP  Search  in  S.  frugiperda  
 
Figure E 1 - Search for Pseudo-attP Sites in S. Frugiperda 
An overview of results from a basic local alignment search of fC31-attP against the S. 
frugiperda genome. No result showed higher that 41% identity. Genome data from 
(Kakumani, Malhotra, Mukherjee, & Bhatnagar, 2014) 
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